Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0824580B2 - New cosmid vector - Google Patents
[go: Go Back, main page]

JPH0824580B2 - New cosmid vector - Google Patents

New cosmid vector

Info

Publication number
JPH0824580B2
JPH0824580B2 JP59112206A JP11220684A JPH0824580B2 JP H0824580 B2 JPH0824580 B2 JP H0824580B2 JP 59112206 A JP59112206 A JP 59112206A JP 11220684 A JP11220684 A JP 11220684A JP H0824580 B2 JPH0824580 B2 JP H0824580B2
Authority
JP
Japan
Prior art keywords
dna
ori
solution
precipitate
cos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59112206A
Other languages
Japanese (ja)
Other versions
JPS60256382A (en
Inventor
正寛 石浦
博 大橋
驍 内田
善雄 岡田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Priority to JP59112206A priority Critical patent/JPH0824580B2/en
Publication of JPS60256382A publication Critical patent/JPS60256382A/en
Publication of JPH0824580B2 publication Critical patent/JPH0824580B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)

Description

【発明の詳細な説明】 本発明は遺伝子操作技術に関し、さらに詳しくは遺伝
子操作技術を使つて作成した新規コスミドベクターに関
する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a gene manipulation technique, and more particularly to a novel cosmid vector prepared by using the gene manipulation technique.

ヒトをはじめとする哺乳動物の遺伝子の大きさは20キ
ロ塩基対(以下キロ塩基対をKbpと略す)を越えるもの
が少なくない。現在、広く使われているラムダベクター
にクローン化できるDNAの大きさは20Kbpなので、これよ
り大きい遺伝子全体を機能のある形でクローン化するこ
とはできない。
The gene size of mammals, including humans, often exceeds 20 kilobase pairs (hereinafter kilobase pairs are abbreviated as Kbp). Since the size of DNA that can be cloned into the widely used lambda vector is 20 Kbp, it is not possible to clone a larger gene in a functional form.

ラムダフアージのcohesive end site(以下cosと略
す)を有するベクター、すなわちコスミドベクターを使
えば35〜45Kbpの大きさのDNAをクローン化できる。種々
のベクターの中で、コスミドベクターが最つとも大きい
長さのDNAをクローン化できるが、長いゲノムDNAの調製
がむづかしいことや、インサートのないベクターだけの
バツクグランドが高いこと、また効率が良くないことな
どが障害になつて、コスミドベクターの利用は進まなか
つた。ところが、Ish−Horowicz & Burkeはホスフアタ
ーゼを利用してベクターに方向性を持たせる工夫をし、
ベクターだけのバツクグランドの値を下げるとともにク
ローン化の効率を上げることに成功した〔D.Ish−Horow
icz & J.F.Burke,Nucleic Acids Res.,9,2889,(198
1)〕。
A DNA having a cohesive end site (hereinafter abbreviated as cos) of lambda phage, that is, a cosmid vector, can be used to clone a DNA having a size of 35 to 45 Kbp. Among various vectors, the cosmid vector can clone the longest DNA, but it is difficult to prepare a long genomic DNA, the background of only the vector without insert is high, and the efficiency is high. The lack of cosmid vectors has hindered the use of cosmid vectors. However, Ish-Horowicz & Burke used a phosphatase to make the vector more directional,
We succeeded in lowering the background value of the vector alone and increasing the cloning efficiency [D.Ish-Horow
icz & JFBurke, Nucleic Acids Res., 9 , 2889, (198
1)].

Ish−Horowicz & Burke法によるゲノムDNAの遺伝子
バンクの製造法は以下のようである(たとえば、現在、
広く使われているコスミドベクターの1つであるpJB−
8を例にとる)。pJB−8は5.44Kbpの大きさで、制限酵
素BamHI,HindIII,SalIでそれぞれ1カ所切断され、ラム
ダフアージのcosを1個有するコスミドベクターであ
る。、pJB−8をHindIIIで切断することによつて直線
状DNAとし、次にホスフアターゼ処理によつてHindIIIの
切断片を不活化する。そして、BamHIで切断することに
よつて2個のDNA断片が得られ、cosを含む大きなDNA断
片(5.4Kbp)をアガロースゲル電気泳動法によつて単離
する。得られたcosを含むDNA断片(5.4Kbp)が、ラムダ
フアージの左腕に相当する。、pJB−8をSalIで切断
することによつて直線状DNAとし、次にホスフアターゼ
で処理することによつてSalIの切断片を不活化する。そ
して、BamHIで切断することによつて2個のDNA断片が得
られ、cosを含む小さなDNA断片(2.34Kbp)をアガロー
スゲル電気泳動法によつて単離する。得られたcosを含
むDNA断片(2.34Kbp)が、ラムダフアージの右腕で相当
する。、たとえば、ヒトのゲノムDNAを制限酵素Sau3A
もしくはMboIで部分的に切断し、35〜45Kbpの大きさのD
NA断片を分画する。この35〜45Kbpの大きさのDNA断片
を、とで別々に調製した左腕と右腕との間に、連結
酵素(T−4−DNAリガーゼ)で挿入させて、組み換え
体DNAを調製する。、組み換え体DNAをin vitroパツケ
ージングで形質導入フアージ粒子に変え、次いで大腸菌
に感染させることによりヒトのゲノムDNAの遺伝子バン
クが製造できる。
The method for producing a gene bank of genomic DNA by the Ish-Horowicz & Burke method is as follows (for example, currently,
PJB-, one of the widely used cosmid vectors
8 as an example). pJB-8 is a cosmid vector having a size of 5.44 Kbp, which is cleaved at one site with each of restriction enzymes BamHI, HindIII and SalI, and has one lambda cos. , PJB-8 is cleaved with HindIII to give linear DNA, and then the HindIII fragment is inactivated by phosphatase treatment. Then, two DNA fragments are obtained by cutting with BamHI, and a large DNA fragment containing cos (5.4 Kbp) is isolated by agarose gel electrophoresis. The obtained DNA fragment containing cos (5.4 Kbp) corresponds to the left arm of lambda phage. , PJB-8 is cleaved with SalI to give a linear DNA, and then treated with phosphatase to inactivate the cut piece of SalI. Then, two DNA fragments are obtained by cutting with BamHI, and a small DNA fragment containing cos (2.34 Kbp) is isolated by agarose gel electrophoresis. The obtained cos-containing DNA fragment (2.34 Kbp) corresponds to the right arm of lambda phage. , For example, the restriction enzyme Sau3A for human genomic DNA
Alternatively, cut it partially with MboI, and use D with a size of 35-45 Kbp.
Fraction NA fragments. The DNA fragment having a size of 35 to 45 Kbp is inserted between the left arm and the right arm, which are separately prepared in and, by a ligase (T-4-DNA ligase) to prepare a recombinant DNA. A gene bank of human genomic DNA can be produced by converting recombinant DNA into transduced phage particles by in vitro packaging and then infecting E. coli.

以上がIsh−Horowicz & Burke法によるゲノムDNAの
遺伝子バンクの製造法であるが、次の3つの問題点があ
る。第1に、pJB−8はcosが1つしかなく、左腕と右腕
とを別々に調製しなければならない。第2に、左腕と右
腕について、それぞれcosを含むDNA断片をアガロースゲ
ル電気泳動で分離しなければならない。第3に、pJB−
8の左腕の長さは5.4Kbp、右腕の長さは2.34Kbpであ
り、左腕と右腕との長さが異なるので、35〜45Kbpのゲ
ノムDNAに連結する確率も異なり、左腕と右腕の混合す
る比率を検討しなければならない。
The above is the method for producing a gene bank of genomic DNA by the Ish-Horowicz & Burke method, but it has the following three problems. First, pJB-8 has only one cos and the left and right arms must be prepared separately. Secondly, DNA fragments containing cos must be separated by agarose gel electrophoresis for each of the left and right arms. Third, pJB-
The length of the left arm of 5.4 is 5.4 Kbp, the length of the right arm is 2.34 Kbp, and the lengths of the left arm and the right arm are different. You must consider the ratio.

本発明者らは、これらの問題点を解決するために、同
一の方向性を持つたラムダフアージのcosを2個有し、
2種類の制限酵素で切ることによつて、それぞれcosを
1個づつ持つた長さのほぼ等しい右腕と左腕が等モルで
きることを特徴とする新規コスミドベクターを作成した
〔第36回日本細胞生物学会大会、講演要旨集、93,94ペ
ージ(1983)〕。
In order to solve these problems, the present inventors have two lambda cos of the same direction,
By cutting with two kinds of restriction enzymes, we created a new cosmid vector characterized by equimolar right arm and left arm each having one cos and having almost the same length [The 36th Annual Meeting of the Japan Society for Cell Biology] Conference, Proceedings, pages 93, 94 (1983)].

本発明のコスミドベクターは、同一分子内に同一の方
向性を持つた2個のcosが存在し、2種類の制限酵素で
切ることによつて、それぞれcosを1個づつ持つた長さ
のほぼ等しい右腕と左腕が等モルできるので、左腕と右
腕とを別々に調製する必要がなく、アガロースゲル電気
泳動で分離する必要もない。さらに、右腕と左腕の長さ
がほぼ等しいので、35〜45KbpのゲノムDNAにT4−DNAリ
ガーゼによつて連結される程度もほぼ等しいと考えてよ
く、2種類の制限酵素で切断してできた右腕と左腕の等
モル混合物を、そのまま35〜45KbpのゲノムDNAと連結す
れば、組み換え体DNAの半分が形質導入フアージ粒子に
変り得ることが期待できる。このように、本発明のベク
ターを用いれば、35〜45KbpのDNA断片として、ゲノムDN
Aの遺伝子バンクをより簡単、かつより効率よく製造で
きる。
The cosmid vector of the present invention has two cos having the same orientation in the same molecule, and by cutting with two kinds of restriction enzymes, each cosmid has a length of approximately one cos. Since the same right arm and left arm can be equimolar, it is not necessary to separately prepare the left arm and the right arm, and it is not necessary to separate them by agarose gel electrophoresis. Furthermore, since the lengths of the right arm and the left arm are almost the same, it can be considered that the degree of ligation to the genomic DNA of 35 to 45 Kbp by T4-DNA ligase is almost the same, and it was cut with two kinds of restriction enzymes. If the equimolar mixture of the right arm and the left arm is ligated with 35-45 Kbp of genomic DNA as it is, it can be expected that half of the recombinant DNA can be transformed into transduction phage particles. Thus, when the vector of the present invention is used, a DNA fragment of 35 to 45 Kbp can be obtained as a genomic DN.
Gene bank A can be manufactured more easily and efficiently.

本発明の新規コスミドベクターの1つであるpDcos Ap
r/oriを第1図に示す〔第36回日本細胞生物学会大会、
講演要旨集93ページ(1983)〕。pDcos Apr/oriは、フ
アージベクターであるCharon4A由来の同一方向性のある
cos2個と、Tn903由来のネオマイシン耐性遺伝子(ne
or)〔Oka,Sugisaki & Takanami,J.Mol.Biol.,147,217
(1981)〕、pBR−327由来のアンピシリン耐性遺伝子
(Apr)及び複製開始点(ori)〔Soberon,Cavarrubias
& Bolivar,Gene,9,287(1980)〕とからなる。大きさ
は4.7Kbpであり、制限酵素PvuII、Bam HI、PstIによつ
てそれぞれ1カ所、制限酵素Bst EIIによつて2カ所、
制限酵素Eco RIによつて3ケ所切断される。このベクタ
ーは次のような特徴を有する。、同一の方向性を持つ
た2つのcosがある。、Bam HIサイトにSau3Aもしくは
MboIなどで限定消化した35〜45KbpのゲノムDNAをクロー
ン化できる。、インサートはBam HIサイトの両側にあ
るEco RIサイトを切ることによつてベクターから切り出
すことができる。、PvuIIでベクターを切断し、ホス
フアターゼ処理することによつて、ベクターに方向性を
持たせ、さらにBam HIサイトを切ることによつて、等モ
ルの右腕と左腕ができる。T4−DNAリガーゼを使つ
て、Sau3AもしくはMboIなどで限定消化した35〜45Kbpの
ゲノムDNAの両側に、ベクターの右腕と左腕をBam HIサ
イトで連結し、組み換え体DNAを、in vitroパツケージ
ングによつて形質導入フアージ粒子に変換し、次いで大
腸菌に感染させることができる。この形質導入体DNA
は、ベクター由来のAprとoriを含むので、アンピシリン
で選択することによつて、組み換え体DNAをプラスミド
として持つ大腸菌のみを選択的に生かすことができる。
また、本ベクターを用いるゲノムDNA(外来DNA)の遺伝
子バンクの製造法を示せば以下のようになる(第2図参
照)。、pDcos Apr/oriをPvuIIで切断することによつ
て直線状DNAとし、次にホスフアターゼ処理によつてPvu
IIの切断片を不活化する。そしてBam HIで切断すること
によつて、それぞれcosを1個づつ持つた長さがほぼ等
しい右腕と左腕とを調製する。、外来DNAをSau3Aもし
くはMboIなどで限定消化し、35〜45Kbpの大きさのDNA断
片を調製する。、35〜45KbpのゲノムDNA断片をで調
製した左腕と右腕との間にT4−DNAリガーゼで挿入させ
て、組み換え体DNAを調製する。、組み換え体DNAをin
vitroパツケージングで形質導入フアージ粒子に変え、
大腸菌に感染させる。、形質導入したアンピシリン耐
性大腸菌をアンピシリンで選択することによつて、組み
換え体DNAをプラスミドとして持つ大腸菌のみを生かす
ことができる。このようにしてゲノムDNAの遺伝子バン
クを製造することができる。
PDcos Ap, which is one of the novel cosmid vectors of the present invention
r / ori is shown in Fig. 1 [36th Annual Meeting of the Japanese Society for Cell Biology,
Abstracts 93 pages (1983)]. pDcos Ap r / ori is unidirectional from the charge vector Charon4A
2 cos and neomycin resistance gene (ne from Tn903)
o r ) 〔Oka, Sugisaki & Takanami, J. Mol. Biol., 147 , 217
(1981)], an ampicillin resistance gene (Ap r ) derived from pBR-327, and an origin of replication (ori) [Soberon, Cavarrubias.
& Bolivar, Gene, 9 , 287 (1980)]. The size is 4.7 Kbp, 1 site for each of the restriction enzymes PvuII, Bam HI and PstI, 2 sites for the restriction enzyme Bst EII,
It is cleaved at 3 sites by the restriction enzyme Eco RI. This vector has the following features. , There are two cos with the same direction. , Bam HI site with Sau3A or
It is possible to clone 35-45 Kbp genomic DNA that has been digested with MboI or the like. The insert can be excised from the vector by cutting the Eco RI sites on both sides of the Bam HI site. , PvuII cleaves the vector and treats it with phosphatase to give the vector directionality, and by cleaving the Bam HI site, equimolar right and left arms are created. The T-DNA ligase was used to ligate the right and left arms of the vector with Bam HI sites on both sides of the 35-45 Kbp genomic DNA that had been digested with Sau3A or MboI, and the recombinant DNA was subjected to in vitro packaging. It can then be transformed into transduced phage particles and then infected with E. coli. This transductant DNA
Contains the vector-derived Ap r and ori, so that by selecting with ampicillin, only E. coli having the recombinant DNA as a plasmid can be selectively utilized.
The method for producing a gene bank of genomic DNA (foreign DNA) using this vector is as follows (see FIG. 2). , PDcos Ap r / ori is digested with PvuII to form linear DNA, and then treated with phosphatase to produce PvuII.
Inactivate the II cut piece. Then, by cutting with Bam HI, a right arm and a left arm each having one cos and having substantially equal lengths are prepared. Then, the foreign DNA is limitedly digested with Sau3A or MboI to prepare a DNA fragment with a size of 35 to 45 Kbp. A recombinant DNA is prepared by inserting a 35-45 Kbp genomic DNA fragment between the left arm and the right arm prepared by using T4-DNA ligase. , Recombinant DNA in
In vitro packaging changes to transduced phagy particles,
Infect E. coli. By selecting the transduced ampicillin-resistant Escherichia coli with ampicillin, only Escherichia coli having the recombinant DNA as a plasmid can be utilized. In this way, a gene bank of genomic DNA can be manufactured.

また、本発明者らはトランスホーマント細胞から遺伝
子回収を目的とするコスミドベクター、pDcos Tcr(第
3図)、pDcos Tcr/ori(第4図)の作成に成功した
(第36回日本細胞生物学会大会、講演要旨集、94ページ
(1983)〕。哺乳動物の培養細胞への遺伝子移入を利用
して哺乳動物のマーカー遺伝子を単離することができ
る。その際、培養細胞に遺伝子移入したDNA配列をトラ
ンスホーマント細胞から大腸菌に回収する作業がある
が、本発明に包含される新規コスミドベクターpDcos Tc
r及びpDcos Tcr/oriは、この遺伝子回収のために有用な
ベクターである。pDcos TcrはCharon4A由来の同一の方
向性のあるcos2個と、pBR−327由来のテトラサイクリン
耐性遺伝子(Tcr)及び複製開始点(ori)とからなる。
pDcos Tcr/oriは、同様にcos2個と、pBR−327由来のTcr
及びoriと、スペーサーとしてのSV−ジヒドロ葉酸リダ
クターゼ遺伝子(SV−dhfr)〔Subramani,Mulligan &
Berg,Mol.Cell.Biol.,1,854(1981)〕とからなる。こ
れらのベクターは、先に述べたpDcosApr/ori(第1図)
と同様な特徴を有しており、同様にこれらを用いてゲノ
ムDNAの遺伝子バンクを製造することができるが、Bam H
Iサイトの代りにBglIIサイトにSau3AもしくはMboIなど
で限定消化した35〜45KbpのゲノムDNAをクローン化でき
る点が異なつている。pDcos Tcrで作成した形質導入フ
アージ粒子はプラスミドのoriを持たないので、大腸菌
に感染しても増殖できない。目的の遺伝子の近傍にori
がある場合にのみテトラサイクリン耐性(Tcr)のクロ
ーンとして目的の遺伝子を大腸菌に回収することができ
る。一方、pDcosTcr/oriで作成した形質導入フアージ粒
子は、oriとTcrマーカーを持つており、Tcrクローンと
してゲノムDNAの遺伝子バンクを作成することができ
る。もし、目的の遺伝子の近傍にAprなどの薬剤耐性マ
ーカーがあれば、アンピシリン耐性(Apr)などの薬剤
耐性クローンとして目的のものだけを選択的に大腸菌に
回収できる。
In addition, the present inventors have succeeded in creating a cosmid vector, pDcos Tc r (Fig. 3) and pDcos Tc r / ori (Fig. 4) for recovering genes from transformant cells (36th Japan). Cell biology society conference, Proceedings, p. 94 (1983)]. Mammalian marker genes can be isolated by using gene transfer into cultured mammalian cells. There is an operation for recovering the prepared DNA sequence from the transformant cells into Escherichia coli, but the novel cosmid vector pDcos Tc included in the present invention is included.
r and pDcos Tc r / ori are useful vectors for this gene recovery. pDcos Tc r consists of 2 cos having the same directionality derived from Charon4A, a tetracycline resistance gene (Tc r ) derived from pBR-327, and an origin of replication (ori).
pDcos Tc r / ori, as well as the cos2 pieces, pBR-327-derived Tc r
And ori and SV-dihydrofolate reductase gene (SV-dhfr) [Subramani, Mulligan &
Berg, Mol. Cell. Biol., 1,854 (1981)]. These vectors are based on pDcosAp r / ori described above (Fig. 1).
It has the same characteristics as those of Bam H and can be used to produce a gene bank of genomic DNA.
The only difference is that instead of the I site, a 35 to 45 Kbp genomic DNA that has been digested with Sau3A or MboI can be cloned into the BglII site. Since the transduction phage particles created in pDcos Tc r does not have the ori of the plasmid, it can not grow even if infected with E. coli. Ori near the gene of interest
The target gene can be recovered in Escherichia coli as a tetracycline-resistant (Tc r ) clone only in the presence of such a gene. On the other hand, the transduction phage particles prepared with pDcosTc r / ori have ori and Tc r markers, and a gene bank of genomic DNA can be prepared as a Tc r clone. If there is a drug resistance marker such as Ap r in the vicinity of the gene of interest, only the desired one can be selectively recovered in E. coli as a drug resistance clone such as ampicillin resistance (Ap r ).

さらに、本発明者らは哺乳動物細胞に対する選択マー
カーを持つていて、哺乳動物細胞への遺伝子移入を目的
とするコスミドベクター、pDcosApr/ori/gpt/TK(第5
図)を作成した。pDcosApr/ori/gpt/TKは、Charon4A由
来の同一方向性のあるcos2個と、pBR−327由来のApr
びori、スペーサーとしてのpSV2−dhfr由来のSV−dhfr
遺伝子、pSV2−gpt由来のgpt遺伝子〔Richard,Mulligan
& Berg,Mol.Cell.Biol.,1,449(1981)〕、及びpTK−
4由来のTK遺伝子〔Ishiura,M.,etal.,Mol.Cell.Biol.,
2,607(1982)〕とからなる。このコスミドベクター
は、前記したpDcosApr/oriと同様に、ゲノムDNAの遺伝
子バンクを製造できる。すなわち、同一の方向性を持つ
た2個のcosがあり、PvuIIとBamHIで切断することによ
り、cosを1個づつ持つた長さがほぼ等しい右腕と左腕
とが等モルでき、BamHIサイトに35〜45KbpのゲノムDNA
を挿入させた組み換え体DNAを作成できる。そして、こ
の組み換え体DNAは、in vitroパツケージングによつて
形質導入フアージ粒子に変換し、大腸菌に移すことがで
き、組み換え体DNAはベクター由来のAprとoriを含むの
で、組み換え体DNAを含む大腸菌は、アンピシリンで選
択することによつて、アンピシリン耐性クローンとして
得ることができる。さらに、この組み換え体プラスミド
は、gpt遺伝子とTK遺伝子を持つので、哺乳動物の培養
細胞への遺伝子移入した際に、キサンチングアニンホス
ホリボシルトランスフエラーゼ(gpt)活性もしくはチ
ミジンキナーゼ(TK)活性をマーカーとすることによつ
て、ベクター由来の組み換え体DNAの挿入の判定が培養
細胞のレベルで可能であるという利点がある。
Furthermore, we have have a selection marker for mammalian cells, cosmid vectors for the purpose of gene transfer into mammalian cells, pDcosAp r / ori / gpt / TK ( Fifth
Figure) was created. pDcosAp r / ori / gpt / TK is cos2 with the same direction derived from Charon4A, Ap r and ori derived from pBR-327, and SV-dhfr derived from pSV2-dhfr as a spacer.
Gene, pSV2-gpt-derived gpt gene [Richard, Mulligan
& Berg, Mol. Cell. Biol., 1, 449 (1981)], and pTK-
4 derived TK gene [Ishiura, M., et al., Mol. Cell. Biol.,
2 , 607 (1982)]. This cosmid vector, like pDcosAp r / ori described above, can produce the gene bank of genomic DNA. That is, there are two cos with the same direction, and by cutting with PvuII and BamHI, the right arm and the left arm having one cos and having almost the same length can be equimolar, and the BamHI site has 35 cos. ~ 45 Kbp genomic DNA
It is possible to create a recombinant DNA in which is inserted. Then, this recombinant DNA can be transformed into transduced phage particles by in vitro packaging and transferred to Escherichia coli. Since the recombinant DNA contains Ap r and ori derived from the vector, it contains the recombinant DNA. E. coli can be obtained as an ampicillin resistant clone by selecting with ampicillin. Furthermore, since this recombinant plasmid has the gpt gene and the TK gene, the xanthine guanine phosphoribosyl tranferase (gpt) activity or the thymidine kinase (TK) activity can be used as a marker when the gene is transferred into cultured mammalian cells. Therefore, there is an advantage that the insertion of the recombinant DNA derived from the vector can be determined at the level of the cultured cells.

本発明に用いられるcosとしては、ラムダフアージま
たはラムドイドフアージ由来のものが挙げられる。特
に、ラムダフアージ由来のcosが好ましいものとして挙
げられる。
Examples of cos used in the present invention include those derived from lambda or lambda. In particular, cos derived from lambda phage is mentioned as a preferable one.

本発明のベクターは、2種類の制限酵素で切ることに
よつて、それぞれcosを1個づつ持つた右腕と左腕がで
きるのであるが、この2種類の制限酵素の組み合せとし
ては、PvuIIとBamHI,PvuIIとBglII,ClaIとBamHI,ClaIと
BglIIなどを挙げることができる。勿論この他にも組合
せは考えることができるので、これらに限定されるもの
ではない。
The vector of the present invention has a right arm and a left arm each having one cos by cutting with two kinds of restriction enzymes. As a combination of these two kinds of restriction enzymes, PvuII and BamHI, PvuII and BglII, ClaI and BamHI and ClaI
BglII etc. can be mentioned. Of course, other combinations can be considered, and the invention is not limited to these.

本発明のベクター中には、ベクター由来のDNA断片が
挿入されたことを、判定するためには一般的に薬剤耐性
による選択が行われる。従つて、本発明のベクター中に
も薬剤耐性を発現するDNA断片が組み込まれていること
が好ましい。薬剤耐性としては、アンピシリン耐性、テ
トラサイクリン耐性、ネオマイシン(カナマイシン)耐
性、もしくはクロラムフエニコール耐性など通常の抗生
物質耐性が挙げられる。pDcos Apr/oriはアンピシリン
耐性遺伝子及びネオマイシン耐性遺伝子を持ち、pDcosT
crとpDcosTcr/oriはテトラサイクリン耐性遺伝子を有し
ている。pDcosApr/ori/gpt/TKはアンピシリン耐性遺伝
子を持つている。
In order to determine that the vector-derived DNA fragment has been inserted into the vector of the present invention, selection by drug resistance is generally performed. Therefore, it is preferable that the vector of the present invention also incorporates a DNA fragment expressing drug resistance. Examples of drug resistance include ordinary antibiotic resistance such as ampicillin resistance, tetracycline resistance, neomycin (kanamycin) resistance, or chloramphenicol resistance. pDcos Ap r / ori has ampicillin resistance gene and neomycin resistance gene, pDcosT
c r and pDcosTc r / ori has a tetracycline resistance gene. pDcosAp r / ori / gpt / TK is with the ampicillin resistance gene.

本発明のベクターを用いてゲノムDNA(外来DNA)の遺
伝子バンクを製造し、哺乳動物の培養細胞へ遺伝子(遺
伝子バンク)移入する際には、ベクター由来のDNA断片
が挿入されたことを判定するために特定の生理機能を発
現するDNA断片が本発明のベクター中に組み込まれてい
るのが好ましい。特定の生理機能を発現せしめる遺伝子
としては、アミノグリコシド3′−ホスホトランスフェ
ラーゼ(neo)遺伝子〔Oka,Sugisaki&Takanami,J.Mol.
Biol.,147,217(1981)〕、チミジンキナーゼ(TK)遺
伝子〔Wigler,M.etal.,Cell,14,725(1978)、アデニン
ホスホリボシルトランスフエラーゼ(APRT)遺伝子〔Wi
gler,M.,etal.,Pro.Natl.Acad.Sci.U.S.A.,76,1373(19
79)〕、ヒポキサンチングアニンホスホリボシルトラン
スフエラーゼ(HGPRT)遺伝子〔Graf,L.H.Jr.,etal,Som
at.Cell.Genet.,5,1031(1979)〕、キサンチングアニ
ンホスホリボシルトランスフエラーゼ(XGPRT又はgpt)
遺伝子〔Berg,P.,etal.Mol.Cell.Biol.,1,449(198
1)〕などが挙げられる。本発明の新規コスミドベクタ
ーpDcosApr/ori/gpt/TKはgpt遺伝子とTK遺伝子を有して
いる。
When a gene bank of genomic DNA (foreign DNA) is produced using the vector of the present invention and the gene (gene bank) is transferred to cultured mammalian cells, it is determined that the vector-derived DNA fragment has been inserted. Therefore, it is preferable that a DNA fragment expressing a specific physiological function is incorporated in the vector of the present invention. Aminoglycoside 3'-phosphotransferase (neo) gene [Oka, Sugisaki & Takanami, J. Mol.
Biol., 147, 217 (1981 ) ], thymidine kinase (TK) gene [Wigler, M.etal., Cell, 14 , 725 (1978), adenine phosphoribosyl trans Hue hydrolase (APRT) gene [Wi
gler, M., etal., Pro.Natl.Acad.Sci.USA, 76 , 1373 (19
79)], hypoxanthine guanine phosphoribosyl transferase (HGPRT) gene [Graf, LHJr., Et al, Som
at.Cell.Genet., 5 , 1031 (1979)], xanthinganine phosphoribosyl transferase (XGPRT or gpt)
Gene [Berg, P., et al. Mol. Cell. Biol., 1,449 (198
1)] and the like. New cosmid vectors pDcosAp r / ori / gpt / TK of the present invention has a gpt gene and the TK gene.

さらに、本発明のベクター中には、ColEI由来の複製
機能を有する遺伝子画分を有することが好ましい。
Further, the vector of the present invention preferably has a gene fraction having a replication function derived from ColEI.

本発明において用いられる外来DNAの例としては、細
菌、糸状菌、酵母などの微生物、高等動植物もしくは各
種フアージ等に由来するDNAが挙げられる。
Examples of the foreign DNA used in the present invention include DNA derived from microorganisms such as bacteria, filamentous fungi, yeasts, higher animals and plants, various types of phages, and the like.

また、本発明において用いられる制限酵素(DNA断片
の特定の塩基配列部位を選択的に切断する機能を有する
酵素)や制限酵素により切断されて生じるDNA接着末端
と、これを相補的な関係のある他のDNA断片接着末端を
結合させる為に用いる酵素(リガーゼ)、あるいは互い
に相補的でないDNA末端同志を結合させるためにDNA末端
同志を互いに相補的な接着末端にする酵素、あるいはこ
れらを結合させるリガーゼについてはすでに良く知ら
れ、数多くの酵素が市販され、それらを用いる手法等に
ついても広く開示されている〔Molecular Cloning,Cold
Spring Harbor Laboratory,Maniatis,T.,etal.,(198
2)〕ので、それらを利用すればよい。
In addition, there is a complementary relationship between the restriction enzyme used in the present invention (enzyme having a function of selectively cutting a specific base sequence site of a DNA fragment) or a DNA sticky end formed by cutting with a restriction enzyme. An enzyme (ligase) used to bond the cohesive ends of other DNA fragments, or an enzyme that makes the cohesive ends of DNA ends complementary to each other to bond DNA ends that are not complementary to each other, or a ligase that connects these Is already well known, many enzymes are commercially available, and methods using them are widely disclosed [Molecular Cloning, Cold
Spring Harbor Laboratory, Maniatis, T., etal., (198
2)], so you can use them.

本発明のベクターを用いることによつて、ヒトをはじ
めとする哺乳動物のガンや遺伝病などを分子レベルで解
析することがより容易となるであろう。たとえば、ヒト
の正常細胞由来のゲノムDNAの遺伝子バンクをpDcos Apr
/oriで作成し、この遺伝子バンクで遺伝病細胞をトラン
スホーム(正常化)し、トランスホーマント細胞を得
る。トランスホーマント細胞からゲノムDNAを抽出し、p
DcosTcrもしくはpDcosTcr/oriでゲノムDNAの遺伝子バン
クを作成し、目的の遺伝子を回収する。目的の遺伝子を
種々の面から検討することによつて、ヒトの遺伝病を分
子レベルで解析することができる。
By using the vector of the present invention, it will be easier to analyze cancer and genetic diseases of mammals including humans at the molecular level. For example, a gene bank of genomic DNA derived from normal human cells is used as pDcos Ap r
/ ori, and transform (normalize) genetically diseased cells with this gene bank to obtain transformant cells. Genomic DNA was extracted from transformant cells and p
Create a gene bank of genomic DNA with DcosTc r or pDcosTc r / ori and recover the target gene. By examining the target gene from various aspects, human genetic diseases can be analyzed at the molecular level.

また、本発明のベクターを用い、ゲノムDNA(外来DN
A)の遺伝子バンクを作成することによつて、有用物質
を発現せしめる特定の遺伝子を効率よく見い出すことが
可能である。この特定の遺伝子とは、細菌、糸状菌、酵
母などの微生物、高等動植物あるいは各種フアージ等に
由来するDNAがあり、具体的な有用物質としては、例え
ば各種ホルモン、酵素、さらには抗生物質やアミノ酸な
どの合成系酵素等が挙げられる。
In addition, using the vector of the present invention, genomic DNA (foreign DN
By creating the gene bank of A), it is possible to efficiently find a specific gene that expresses a useful substance. This specific gene includes DNA derived from bacteria, filamentous fungi, microorganisms such as yeast, higher animals and plants or various types of phages, and specific useful substances include, for example, various hormones, enzymes, and further antibiotics and amino acids. And other synthetic enzymes.

以下、実施例を示して本発明をいつそう詳細に説明す
る。
Hereinafter, the present invention will be described in more detail with reference to Examples.

実施例1 pDcosTcrの作成及び調製(第6図) (a)pAPcosの作成及び調製 i)作成 フアージベクターであるCharon4A由来のcosを1個有
するコスミドベクターであるpHC79〔Hohn & Collins,G
ene,11,291(1980)〕20μgを、反応混液200μl(10m
MTris−HCl(pH7.6)、12mM MgCl2、10m MDTT、100μg/
ml BSA(ウシ血清アルブミン)で、29.9ユニツトの制限
酵素BalI(New England Biolabs社製)と37℃で2時間
反応させて完全に消化したのち、さらに反応混液500μ
l(150mM NaCl,6mM Tris−HCl(pH7.9)、6mM MgCl2
6mMDTT、100μg/μl BSA〕で、41.1ユニツトの制限酵素
Bst EII(New England Biolabs社製)と60℃で2時間反
応させて完全に消化した。反応終了後、等量の水飽和フ
エノールで抽出を行ない、水層をセカンダリブタノール
で濃縮後、0.1倍容量の3M酢酸ナトリウムと2倍容量の
エタノールを加えて、DNAを沈澱として得、95%エタノ
ールで洗つたのち、水流ポンプで乾燥を行ない、沈澱を
10mM Tris−HCl(pH8.0)、0.1mMEDTAからなる水溶液
(以下10t/0.1Eと略す)14μl(〜1μg/μl)に溶解
させた。
Example 1 PDcosTc r creation and preparation (Figure 6) (a) pAPcos creation and cos derived Charon4A is prepared i) creating full Urge vector is a cosmid vector having one pHC79 [Hohn & Collins, G
ene, 11 , 291 (1980)] 20 μg to the reaction mixture 200 μl (10 m
MTris-HCl (pH7.6), 12mM MgCl 2, 10m MDTT, 100μg /
Completely digest with 29.9 units of restriction enzyme BalI (New England Biolabs) at 37 ° C for 2 hours with ml BSA (bovine serum albumin), and then add 500 µ of the reaction mixture.
1 (150 mM NaCl, 6 mM Tris-HCl (pH 7.9), 6 mM MgCl 2 ,
6mMDTT, 100μg / μl BSA], 41.1 unit restriction enzyme
Bst EII (manufactured by New England Biolabs) was reacted at 60 ° C. for 2 hours for complete digestion. After the reaction was completed, extraction was performed with an equal volume of water-saturated phenol, the aqueous layer was concentrated with secondary butanol, 0.1 volume of 3M sodium acetate and 2 volume of ethanol were added to obtain DNA as a precipitate, and 95% ethanol was added. After washing with water, it is dried with a water pump to prevent precipitation.
It was dissolved in 14 μl (up to 1 μg / μl) of an aqueous solution (hereinafter abbreviated as 10 t / 0.1E) consisting of 10 mM Tris-HCl (pH 8.0) and 0.1 mM EDTA.

次に、このBalI及びBstEIIで消化したDNA溶液1μl
(〜1μg)を反応混液25μl〔50mM Tris−HCl(pH7.
2)、10mMMgSO4、0.1mM DTT、50μg/mlBSA、80μM dCT
R、80μMdGDP、80μM dATP、80μMdTTp〕で、2ユニツ
トのKlenow酵素(Boehringer Mannheim社製)と22℃で3
0分間反応させて、互いに相補鎖が存在する2本鎖DNA断
片(cohesive end)を両端がそろつた2本鎖DNA断片(b
lunt end)に変えた。反応終了後、反応液を65℃で10分
間熱処理してKlenow酵素を失活させた。
Next, 1 μl of this DNA solution digested with BalI and BstEII
(~ 1 μg) was added to the reaction mixture 25 μl [50 mM Tris-HCl (pH 7.
2), 10 mM MgSO 4 , 0.1 mM DTT, 50 μg / ml BSA, 80 μM dCT
R, 80 μM dGDP, 80 μM dATP, 80 μM dTTp] and 2 units of Klenow enzyme (Boehringer Mannheim) at 22 ° C.
After reacting for 0 minutes, a double-stranded DNA fragment (b) having complementary ends to each other has a double-stranded DNA fragment (cohesive end) aligned (b).
lunt end). After completion of the reaction, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate the Klenow enzyme.

そして、この液10μl(DNA〜0.4μg)を反応混液50
μl(50mM Tris−HCl(pH7.4)、10mM MgCl2、10mMDT
T、1mMスペルミジン、1mM ATP、100μg/mlBSA)で、15
ユニツトのT4−DNAリガーゼ(New England Biolabs社製
と12℃で17.5時間反応させて、cos及びori,Apr 1Tcrを含
むDNA断片(4.75Kbp)を閉環化させた。反応終了後、フ
エノール抽出を行なつたのち、DNAをエタノール沈澱と
して得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに
溶解させた。
Then, add 10 μl of this solution (DNA ~ 0.4 μg) to the reaction mixture 50
μl (50 mM Tris-HCl (pH7.4), 10 mM MgCl 2 , 10 mM DT
T, 1 mM spermidine, 1 mM ATP, 100 μg / ml BSA), 15
T4-DNA ligase (reacted manufactured by New England Biolabs and 17.5 hours at 12 ° C. of Yunitsuto was cos and ori, DNA fragments containing Ap r 1 Tc r a (4.75Kbp) is closed reduction. After the completion of the reaction, phenol After extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

ii)トランスホーメーシヨン このDNA溶液10μlを大腸菌HB101のcompetent cell 1
00μl(対数増殖期の大腸菌HB101を0〜4℃で0.1M Ca
Cl2溶液で15分間処理後、もとの培養液の1/10溶量の0.1
M CaCl2/14%glycerol溶液に再懸濁し、−70℃に保存)
とよく混合し、0℃で10分間、続いて37℃で5分間保温
して、DNAを大腸菌内に取りこませたのち、これにL−
ブロス(1%Bactotryptone,0.5%酵母エキス0.5%NaC
l,0.1%グルコース)2mlを加えて、37℃で1時間振盪培
養した。この菌体懸濁液を20μg/mlのアンピシリン及び
20μg/mlのテトラサイクリンを含むL−プレート(L−
ブロースに寒天を1%添加したプレート)上にまき、37
℃で24〜48時間培養し、アンピシリン及びテトラサイク
リン耐性のクローンを得た。
ii) Transformation 10 μl of this DNA solution was added to competent cell 1 of Escherichia coli HB101.
00μl (logarithmic growth E. coli HB101 at 0-4 ° C with 0.1M Ca
After treatment with Cl 2 solution for 15 minutes, 0.1 / 10 of the original culture solution was added.
Resuspend in M CaCl 2 /14% glycerol solution and store at -70 ° C)
After mixing well with 0 ° C for 10 minutes and then at 37 ° C for 5 minutes to take up the DNA into E. coli, L-
Broth (1% Bactotryptone, 0.5% Yeast Extract 0.5% NaC
2 ml of 0.1% glucose) was added, and the mixture was cultured at 37 ° C. for 1 hour with shaking. This cell suspension was treated with 20 μg / ml ampicillin and
L-plate containing 20 μg / ml tetracycline (L-
Sprinkle the broth on a plate containing 1% agar, 37
After culturing at 48 ° C for 24-48 hours, ampicillin- and tetracycline-resistant clones were obtained.

iii)少量培養、及び少量DNA調製 Apr 1TcrであるクローンをL−ブロス2ml中(Ap20μg/
ml含有)で37℃、1晩振盪して、増殖させた。培養液1.
5mlをエツペンドルフチユーブにとり、机上遠心分離機
にかけて集菌後、この菌体を抽出液(8%シヨ糖、0.5
%TritonX−100,50mMEDTA(pH8.0)、10mM Tris−HCl
(pH8.0))0.35mlに再懸濁させた。次に、リゾチーム
溶液25μl〔10mg/ml、10mM Tris−HCl(pH8.0)〕を加
え混合したのち、チユーブを沸騰水中に40秒間おいた。
そして、直ちにチユーブを4℃にて遠心分離機(21,000
rpm、15分間)にかけて上澄液を得、これにRNaseA溶液
(20mg/ml、10t/0.1E)0.5μlを加えて37℃で1時間保
温してRNAを分解させた。その後、フエノール抽出で除
蛋白後、DNAをエタノール沈澱として得、沈澱を10t/0.1
E20μlに溶解させて、プラスミドDNA溶液を得た。
iii) Small amount culture and small amount DNA preparation Ap r 1 Tc r clone was added to 2 ml of L-broth (Ap 20 μg /
The cells were grown by shaking at 37 ° C. (containing ml) overnight. Culture medium 1.
Take 5 ml of Eppendorf tube and collect the cells in a desktop centrifuge, and extract the cells (8% sucrose, 0.5%).
% TritonX-100, 50 mM EDTA (pH8.0), 10 mM Tris-HCl
(PH 8.0)) and resuspended in 0.35 ml. Next, 25 μl of a lysozyme solution [10 mg / ml, 10 mM Tris-HCl (pH 8.0)] was added and mixed, and then the tube was placed in boiling water for 40 seconds.
Then immediately put the tube in a centrifuge (21,000
The supernatant was obtained at 50 rpm for 15 minutes, and 0.5 μl of RNase A solution (20 mg / ml, 10 t / 0.1E) was added to the supernatant, and the mixture was kept at 37 ° C. for 1 hour to decompose RNA. Then, after deproteinizing with phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was extracted with 10 t / 0.1
It was dissolved in 20 μl of E to obtain a plasmid DNA solution.

iv)プラスミドDNAの特性化 そして、このプラスミドDNA溶液1μl又は2μlを
制限酵素EcoRI,BstEII,BglII,PvuIIなどで消化したの
ち、0.4〜1.5%アガロースゲル電気泳動〔40mM Tris,20
mM酢酸ナトリウム、2mM EDTA(pH8.15);10mA,12〜24時
間〕にかけた。分解されたDNA断片は臭化エチジウム染
色と長波長紫外線照明によつて検出できる。このように
して、プラスミドDNAの制限地図を作成することによつ
て、各クローンが持つているプラスミドDNAを特性化し
た。そして、PHC79のBalIサイトとBstEIIサイトの間のD
NA断片(1.68Kbp)を欠いたプラスミド:pAPcos(第6
図)を持つ大腸菌を得た。
iv) Characterization of plasmid DNA Then, 1 μl or 2 μl of this plasmid DNA solution was digested with restriction enzymes EcoRI, BstEII, BglII, PvuII, etc., and then 0.4-1.5% agarose gel electrophoresis [40 mM Tris, 20
mM sodium acetate, 2 mM EDTA (pH8.15); 10 mA, 12-24 hours]. Degraded DNA fragments can be detected by ethidium bromide staining and long wavelength UV illumination. In this way, the plasmid DNA carried by each clone was characterized by constructing a restriction map of the plasmid DNA. And D between the BalI site and the BstEII site of PHC79
Plasmid lacking NA fragment (1.68 Kbp): pAPcos (6th
E. coli having (Fig.) Was obtained.

V)大量培養、及びプラスミドDNAの調製 この大腸菌を、TYG−P培地(1%Bactotryptone,0.1
%酵母エキス、0.2%グルコース、0.1% NH4Cl,0.3%
NaCl,0.01% Na2SO4,0.08%MgCl2・6H2O,1.52% Na2
HPO4・12H2O,0.3% KH2PO4)1中で(Ap20μg/ml含
有)、37℃で振盪培養し、600nmでの吸光度(A600)が
1.0になつた時点で、クロラムフエニコールを100μg/ml
の濃度になるように添加し、さらに15時間37℃で振盪培
養した。培養終了後、遠心分離機(6,000rpm,10分間)
にかけて集菌を行ない、次に菌体を25%シヨ糖、50mM T
ris−HCl(pH8.0)からなる等張緩衝液18mlに再懸濁し
た。これに、リゾチーム溶液〔5mg/ml、0.25M Tris−HC
l(pH8.0)〕3.6mlを加え、おだやかに混合し、0℃で
5分間おいたのち、0.25MEDTA(pH8.0)溶液7.2mlを加
え、おだやかに混合し、0℃で5分間おいた。その後、
10%SDS溶液2.7mlと5M NaCl溶液8.1mlとを加えおだやか
に混合し、0℃で1晩おいたのち、遠心分離機(20,000
rpm,45分間)にかけて粗溶菌液(cleared lysate)〜39
mlを得た。この粗溶菌液に、RNaseA溶液(20mg/ml,10t/
0.1E)20μlを加えて37℃にて1時間保温してRNAを分
解させたのち、フエノール抽出で除蛋白を行ない、さら
にセフアロース2Bのゲルロ過にかけた。プラスミドDNA
を含むボイドフラクシヨンから、DNAをエタノール沈澱
として得、次にDNAを塩化セシウム−臭化エチジウム溶
液〔1M Tris−HCl(pH8.0)0.375ml、0.25MEDTA(pH8.
0)0.30ml、H2O6.45ml、CsCl7.5g、EtBr溶液(4mg/ml)
0.375ml〕で平衡密度勾配遠心(60,000rpm12時間)にか
けた。そうすると、共有結合で閉鎖された環状のプラス
ミドDNA(ccc−DNA)は、遠沈管中で長波長紫外線照射
下において、線状のプラスミドDNA及び染色体のけい光
帯の下にバンド状に見えてくる。このccc−DNAのバンド
を分画し、CsCl水溶液で飽和したイソプロパノールで抽
出を行なつて、臭化エンジウムを取り除いた後、10t/0.
1E 1に対して透析を行なつた。そして、透析内液か
ら、ccc−DNAをエタノール沈澱として得、沈澱を10t/0.
1E2mlに溶解させてpAPcosのプラスミドDNA溶液(0.418m
g/ml)を調製した。
V) Mass culture and preparation of plasmid DNA This E. coli was cultured in TYG-P medium (1% Bactotryptone, 0.1%).
% Yeast extract, 0.2% glucose, 0.1% NH 4 Cl, 0.3%
NaCl, 0.01% Na 2 SO 4 , 0.08% MgCl 2 · 6H 2 O, 1.52% Na 2
HPO 4・ 12H 2 O, 0.3% KH 2 PO 4 ) 1 (containing Ap 20 μg / ml), shake culture at 37 ℃, the absorbance at 600 nm (A600)
Chloramphenicol at 100 μg / ml at 1.0
Was added so that the concentration would become, and the mixture was further cultured by shaking at 37 ° C. for 15 hours. After culturing, centrifuge (6,000 rpm, 10 minutes)
The cells were harvested over time, and then the cells were washed with 25% sucrose and 50 mM T.
It was resuspended in 18 ml of isotonic buffer consisting of ris-HCl (pH 8.0). Add lysozyme solution (5 mg / ml, 0.25M Tris-HC
l (pH8.0)] 3.6 ml, gently mix and stir at 0 ° C for 5 minutes, then add 0.25M EDTA (pH8.0) solution 7.2 ml, gently mix and stir at 0 ° C for 5 minutes I was there. afterwards,
2.7 ml of 10% SDS solution and 8.1 ml of 5M NaCl solution were added and gently mixed, and the mixture was allowed to stand at 0 ° C. overnight and then centrifuged (20,000
rpm, 45 minutes) to a crude lysate ~ 39
I got ml. RNase A solution (20 mg / ml, 10 t /
After adding 20 μl of 0.1E) and incubating at 37 ° C. for 1 hour to decompose RNA, deproteinization was carried out by phenol extraction, and the gel was filtered with Sepharose 2B. Plasmid DNA
DNA was obtained as an ethanol precipitate from a void fraction containing EDTA, and then the DNA was cesium chloride-ethidium bromide solution (1M Tris-HCl (pH 8.0) 0.375 ml, 0.25 M EDTA (pH 8.
0) 0.30ml, H 2 O6.45ml, CsCl7.5g, EtBr solution (4 mg / ml)
0.375 ml] and subjected to equilibrium density gradient centrifugation (60,000 rpm, 12 hours). Then, the covalently closed circular plasmid DNA (ccc-DNA) appears as a band under the fluorescent band of the linear plasmid DNA and the chromosome in the centrifuge tube under long-wavelength ultraviolet irradiation. . This ccc-DNA band was fractionated and extracted with isopropanol saturated with a CsCl aqueous solution to remove endium bromide, then 10 t / 0.
Dialysis was performed on 1E 1. Then, ccc-DNA was obtained as an ethanol precipitate from the dialysate, and the precipitate was 10 t / 0.
Dissolve in 2 ml of 1E and pAPcos plasmid DNA solution (0.418 m
g / ml) was prepared.

(b)pAPcosΔ(EcoRI)の作成及び調製 pAPcos10μgを反応混液100μl(100mM Tris−HCl
(pH7.5)、50mM NaCl、5mM MgCl2、100μg/ml BSA)
で、60.6ユニツトの制限酵素EcoRI(New England Biola
bs社製)と37℃で2時間反応させて完全に消化した。そ
して、フエノール抽出で除蛋白後、DNAをエタノール沈
澱として得、沈澱を10t/0.1E 7μl(〜1μg/μl)に
溶解させた。
(B) Preparation and preparation of pAPcosΔ (EcoRI) 10 μg of pAPcos was mixed with 100 μl of the reaction mixture (100 mM Tris-HCl).
(PH 7.5), 50 mM NaCl, 5 mM MgCl 2 , 100 μg / ml BSA)
The 60.6 unit restriction enzyme EcoRI (New England Biola
bs) and reacted at 37 ° C. for 2 hours for complete digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 7 µl (~ 1 µg / µl).

次に、このEcoRIで消化したDNA溶液1μl(〜1μ
g)を反応混液25μl(50mM Tris−HCl(pH7.2)、10m
M MgSO4、0.1mM DTT、50μg/mlBSA、80μM dATP,80μM
dCTP,80μM dGTP,80μM dTTP)で、2ユニツトのKlenow
酵素と22℃で30分間反応させて、cohesive endをblunt
endに変えた。そして、反応液を65℃で10分間熱処理し
てKlenow酵素を失活させた。
Next, 1 μl of this DNA solution digested with EcoRI (up to 1 μl
g) to the reaction mixture 25 μl (50 mM Tris-HCl (pH7.2), 10 m
M MgSO 4 , 0.1 mM DTT, 50 μg / ml BSA, 80 μM dATP, 80 μM
dCTP, 80 μM dGTP, 80 μM dTTP) with 2 units of Klenow
React with enzyme for 30 minutes at 22 ℃ and blunt the cohesive end.
I changed it to end. Then, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate the Klenow enzyme.

次に、このDNA溶液10μl(〜0.4μg)を反応混液50
μl(50mM Tris−HCl(pH7.4)、10mM MgCl2、10mM DT
T,1mMスペルミジン、1mMATP,100μg/mlBSA)で、15ユニ
ツトのT4−DNAリガーゼと12℃で17.5時間反応させて閉
環化したのちフエノール抽出を行ない、DNAをエタノー
ル沈澱として得、沈澱を0.1MT ris−HCl(pH7.5)溶液2
0μlに溶解させた。
Next, add 10 μl (~ 0.4 μg) of this DNA solution to the reaction mixture 50
μl (50 mM Tris-HCl (pH7.4), 10 mM MgCl 2 , 10 mM DT
T, 1 mM spermidine, 1 mM ATP, 100 μg / ml BSA) was reacted with 15 units of T4-DNA ligase at 12 ° C. for 17.5 hours for cyclization, followed by phenol extraction to obtain DNA as an ethanol precipitate. The precipitate was 0.1 MT ris. -HCl (pH 7.5) solution 2
It was dissolved in 0 μl.

そして、このDNA溶液10μlで大腸菌(HB101)とトラ
ンスホーメーシヨンしたのち、AprかつTcrクローンを得
た。次に、これらのクローンについて少量培養及び少量
DNA調製を行なつたのち、各クローンのもつプラスミドD
NAの特性を調べて、pAPcosのEcoRIサイトを欠いたプラ
スミド:pAPcosΔ(EcoRI)(第6図)を持つ大腸菌を得
た。
After transformation with 10 μl of this DNA solution with E. coli (HB101), Ap r and Tc r clones were obtained. Next, small amount culture and small amount of these clones
After DNA preparation, plasmid D of each clone
By examining the characteristics of NA, Escherichia coli harboring a plasmid lacking the EcoRI site of pAPcos: pAPcosΔ (EcoRI) (Fig. 6) was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpAPcosΔ(EcoR
I)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pAPcosΔ (EcoR
The plasmid DNA of I) was prepared.

(c)pHPcosの作成及び調製 pAPcosΔ(EcoRI)20μgを、反応混液200μl〔60mM
NaCl,6mM Tris HCl(pH8.0)、10mM MgCl2 6mM DTT,10
0μg/mlBSA〕で75.8ユニツトの制限酵素AvaI(New Engl
and Biolabs社製)と37℃で2時間反応させて完全に消
化したのち、さらに反応混液500μl〔60mM NaCl,7mM T
ris−HCl(pH7.4)、7mM MgCl2,100μg/mlBSA〕で、101
ユニツトの制限酵素HindIII(New England Biolabs社
製)と37℃で2時間反応させて完全に消化した。そし
て、フエノール抽出で除蛋白後、DNAをエタノール沈澱
として得、沈澱を10t/0.1E 14μl(〜1μg/μl)に
溶解させた。
(C) Preparation and preparation of pHPcos 20 μg of pAPcosΔ (EcoRI) was added to 200 μl of the reaction mixture [60 mM.
NaCl, 6mM Tris HCl (pH8.0) , 10mM MgCl 2 6mM DTT, 10
0 μg / ml BSA] with 75.8 unit restriction enzyme AvaI (New Engl
and Biolabs) at 37 ° C for 2 hours for complete digestion, and then 500 µl of the reaction mixture [60 mM NaCl, 7 mM T
ris-HCl (pH7.4), 7 mM MgCl 2 , 100 μg / ml BSA],
The product was completely digested by reacting with the unit restriction enzyme HindIII (New England Biolabs) at 37 ° C. for 2 hours. Then, after deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 14 μl (˜1 μg / μl).

次に、このAvaIとHindIIIで消化したDNA溶液1μl
(〜1μg)を、反応混液25μlで、2ユニツトのKlen
ow酵素と22℃で30分間反応させて、cohesive endをblun
t endに変えた。そして、反応液を65℃で10分間熱処理
してKlenow酵素を失活させた。
Next, 1 μl of this DNA solution digested with AvaI and HindIII
(~ 1 μg) in 25 μl of reaction mixture, 2 units of Klen
ow the enzyme with ow enzyme for 30 minutes at 22 ℃ and blun the cohesive end.
changed to t end. Then, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate the Klenow enzyme.

次に、このDNA溶液10μl(〜0.4μg)を反応混液50
μlで、15ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて、cos及びori,Aprを含むDNA断片(3.75Kb
p)を閉環化させた(HindIIIサイトは再構成される)。
その後、フエノール抽出を行ない、DNAをエタノール沈
澱として得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μ
lに溶解させた。
Next, add 10 μl (~ 0.4 μg) of this DNA solution to the reaction mixture 50
After reacting with 15 μl of T4-DNA ligase at 12 ° C. for 17.5 hours, the DNA fragment containing cos, ori and Ap r (3.75 Kb
p) was cyclized (HindIII site was reconstructed).
Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 20 μm.
It was dissolved in 1.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、AprかつTcs(テトラサイ
クリン感受性)クローンを得た。次でこれらのクローン
のもつプラスミドDNAの特性を調べて、pAPcosΔ(EcoR
I)のAvaIサイトとHindIIIサイトの間のDNA断片(1Kb
p)を欠いたプラスミド:pHPcos(第6図)を持つ大腸菌
を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc s (tetracycline sensitive) clones were obtained. Next, the characteristics of the plasmid DNA possessed by these clones were examined, and pAPcosΔ (EcoR
I) between the AvaI site and the HindIII site (1 Kb
Escherichia coli having a plasmid lacking p): pHPcos (Fig. 6) was obtained.

この大腸菌をTYG−P培地1中で増殖させたのち、
菌体よりccc−DNAを分離精製してpHPcosのプラスミドDN
Aを調製した。
After growing this E. coli in TYG-P medium 1,
Ccc-DNA was isolated and purified from the bacterial cells to obtain the plasmid DN of pHPcos.
A was prepared.

(d)pHBglIIcosの作成及び調製 pHPcos10μgを、反応混液100μl〔60mM NaCl,6mM T
ris−HCl(pH7.5)、6mM MgCl2 6mM DTT,100μg/mlBS
A〕で、51.2ユニツトの制限酵素PvuII(Takara社製)と
37℃で2時間反応させて完全に消化した。(blunt en
d)。そして、フエノール抽出で除蛋白後、DNAをエタノ
ール沈澱として得、沈澱を10t/0.1E 7μl(〜1μg/μ
l)に溶解させた。
(D) Preparation and preparation of pHBglIIcos 10 μg of pHPcos was mixed with 100 μl of reaction mixture [60 mM NaCl, 6 mM T
ris-HCl (pH 7.5), 6 mM MgCl 2 6 mM DTT, 100 μg / ml BS
A] with 51.2 unit restriction enzyme PvuII (Takara)
The reaction was carried out at 37 ° C for 2 hours for complete digestion. (Blunt en
d). After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1E 7 µl (~ 1 µg / µ
l).

次に、このPvuIIで消化したDNA溶液0.4μl(〜0.4μ
g)とBglIIリンカー〔d(pC−A−G−A−T−C−
T−G)〕2μgとを、反応混液20μl〔50mM Tris−H
Cl(pH7.4)、10mM MgCl2,10mM DTT,1mMスペルミジン、
1mM ATP,100μg/mlBSA〕で、6ユニツトのT4−DNAリガ
ーゼと22℃で6時間反応させて連結した。その後フエノ
ール抽出を行ない、DNAをエタノール沈澱として得た。
Next, 0.4 μl of the DNA solution digested with PvuII (up to 0.4 μl
g) and a BglII linker [d (pC-A-G-A-T-C-
TG)] 2 μg and 20 μl of reaction mixture [50 mM Tris-H
Cl (pH7.4), 10 mM MgCl 2 , 10 mM DTT, 1 mM spermidine,
1 mM ATP, 100 μg / ml BSA] and ligated by reacting with 6 units of T4-DNA ligase at 22 ° C. for 6 hours. After that, phenol extraction was performed to obtain DNA as an ethanol precipitate.

このDNA沈澱を、反応混液250μl〔60mM NaCl,10mM T
ris−HCl(pH7.4)、10mM MgCl2,10mMDTT,100μg/mlBS
A〕で、200ユニツトの制限酵素BglII(Takara社製)と3
7℃で4時間反応させて消化したのち、0.8%調製用アガ
ロースゲルにかけて、10mAで12時間電気泳動した。分解
されたDNA断片は臭化エチジウム染色と長波長紫外線照
明によつて見えてくる。cos及びori,AprからなるDNA断
片(2.55Kbp)を含有するゲルを切り出したのち、5倍
容量の抽出液(0.5M NH4OAc,1mM EDTA(pH7.5):水飽
和フエノール=1:1)の存在下で、ゲルをすりつぶしてD
NAを溶出させた。そして、溶出液をセカンダリーブタノ
ールで濃縮後、0.1倍容量の3M酢酸ナトリウムと2倍容
量のエタノールを加えてDNAを沈澱として得た。
This DNA precipitate was added to 250 μl of the reaction mixture [60 mM NaCl, 10 mM T
ris-HCl (pH7.4), 10 mM MgCl 2 , 10 mM DTT, 100 μg / ml BS
A], 200 units of restriction enzyme BglII (Takara) and 3
After reacting at 7 ° C for 4 hours for digestion, the mixture was applied to 0.8% preparative agarose gel and electrophoresed at 10 mA for 12 hours. Degraded DNA fragments are visible by ethidium bromide staining and long-wavelength UV illumination. A gel containing a DNA fragment (2.55 Kbp) consisting of cos, ori, and Ap r was cut out, and then extracted with 5 volumes of an extract (0.5 M NH 4 OAc, 1 mM EDTA (pH 7.5): water-saturated phenol = 1 :). In the presence of 1), mash the gel and D
NA was eluted. Then, the eluate was concentrated with secondary butanol, and 0.1 times volume of 3M sodium acetate and 2 times volume of ethanol were added to obtain DNA as a precipitate.

このDNA沈澱を反応混液20μlで、6ユニツトのT4−D
NAリガーゼと12℃で17.5時間反応させて、cos及びori,A
prからなるDNA断片(2.55Kbp)を閉環化させた。その
後、フエノール抽出を行ない、DNAをエタノール沈澱と
して得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに
溶解させた。
This DNA precipitate was treated with 20 μl of the reaction mixture to prepare 6 units of T4-D.
After reacting with NA ligase at 12 ℃ for 17.5 hours, cos and ori, A
The DNA fragment consisting of p r (2.55 Kbp) was closed. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Aprクローンを得た。次
で、これらのクローンのもつプラスミドDNAの特性を調
べて、pHPcosのPvuIIサイトにBglIIリンカーを挿入させ
たプラスミド:pHBglIIcos(第6図)を持つ大腸菌を得
た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Next, the characteristics of the plasmid DNA of these clones were examined to obtain Escherichia coli having the plasmid: pHBglIIcos (Fig. 6) in which the BglII linker was inserted into the PvuII site of pHPcos.

この大腸菌を、TYG−P培地1で増殖させたのち、
菌体よりccc−DNAを分離精製してpHBglIIcosのプラスミ
ドDNAを調製した。
After growing this E. coli in TYG-P medium 1,
The ccc-DNA was separated and purified from the cells to prepare a pHBglIIcos plasmid DNA.

(e)pAPcos(BglII)の作成及び調製 pAPcos10μgを、反応混液100μlで60.6ユニツトのE
coRIと37℃で2時間反応させて消化した。そして、フエ
ノール抽出で除蛋白後、DNAをエタノール沈澱として
得、沈澱を10t/0.1E 7μl(〜1μg/μl)に溶解させ
た。
(E) Preparation and preparation of pAPcos (BglII) 10 μg of pAPcos was added to 100 μl of the reaction mixture to obtain 60.6 units of E.
It was digested by reacting with coRI at 37 ° C for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 7 µl (~ 1 µg / µl).

次に、このEcoRIで消化したDNA溶液1μl(〜1μ
g)を、反応混液25μlで、2ユニツトのKlenow酵素と
22℃で30分間反応させて、cohesive endをblunt endに
変えた。そして反応液を65℃で10分間熱処理してKlenow
酵素を失活させた。
Next, 1 μl of this DNA solution digested with EcoRI (up to 1 μl
g) in a reaction mixture of 25 μl with 2 units of Klenow enzyme
The reaction was performed at 22 ° C for 30 minutes, and the cohesive end was changed to blunt end. Then heat the reaction mixture at 65 ° C for 10 minutes and heat it to Klenow.
The enzyme was inactivated.

次に、このDNA溶液10μl(0.4μg)とBglIIリンカ
ー〔d(pC−A−G−A−T−C−T−G)〕2μgと
を、反応混液20μlで、6ユニツトのT4−DNAリガーゼ
と22℃で6時間反応させて連結した。
Then, 10 μl (0.4 μg) of this DNA solution and 2 μg of BglII linker [d (pC-A-G-A-T-C-T-T-G)] were mixed with 20 μl of a reaction mixture to prepare 6 units of T4-DNA ligase. Was reacted at 22 ° C. for 6 hours for ligation.

そして、この反応液10μlを、反応混液50μlで、15
ユニツトのT4−DNAリガーゼと12℃で17.5時間反応させ
て、cos及びori,Apr.TcrからなるDNA断片(4.75Kbp)
を閉環化させた。その後、フエノール抽出を行ないDNA
をエタノール沈澱として得、沈澱を0.1M Tris−HCl(pH
7.5)溶液20μlに溶解させた。
Then, add 10 μl of this reaction solution to 50 μl of the reaction mixture,
After reacting with unit T4-DNA ligase at 12 ° C. for 17.5 hours, cos and ori, Ap r . DNA fragment consisting of Tc r (4.75Kbp)
Was closed. After that, phenol extraction was performed
Was obtained as an ethanol precipitate, and the precipitate was mixed with 0.1 M Tris-HCl (pH
7.5) Dissolved in 20 μl of solution.

このDNA溶液10μlで大腸菌(HB101)をトランスホー
メーシヨンしたのち、AprかつTcrクローンを得た。次い
で、これらのクローンのもつプラスミドDNAの特性を調
べて、pAPcosのEcoRIサイトにBglIIリンカーを挿入させ
たプラスミド:pAPcos(BglII)(第6図)を持つ大腸菌
を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc r clones were obtained. Then, the characteristics of the plasmid DNA of these clones were examined to obtain Escherichia coli having the plasmid: pAPcos (BglII) (Fig. 6) in which the BglII linker was inserted into the EcoRI site of pAPcos.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpAPcos(BglII)
のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pAPcos (BglII).
Was prepared.

(f)pDcos Apr/Tcr(2BglII)の作成及び調製 pAPcos(BglII)20μgを、反応混液200μlで202ユ
ニツトのBglIIと37℃で2時間反応させて消化したの
ち、0.8%調製用アガロースゲル電気泳動にかけて、cos
及びTcrを含むDNA断片(1.86Kbp)を分離精製して、DNA
をエタノール沈澱として得、沈澱を10t/0.1E 5.5μl
(〜1μg/μl)に溶解させた。
(F) Preparation and preparation of pDcos Ap r / Tc r (2BglII) 20 μg of pAPcos (BglII) was reacted with 202 units of BglII in 200 μl of the reaction mixture at 37 ° C. for 2 hours for digestion, and then 0.8% for preparation agarose gel. Electrophoresis, cos
And it was separated and purified DNA fragment (1.86Kbp) containing Tc r, DNA
Is obtained as an ethanol precipitate, and the precipitate is 10t / 0.1E 5.5 μl
(˜1 μg / μl).

一方、pHBglIIcos10μgを、反応混液100μlで94ユ
ニツトのBglIIと37℃で2時間反応させて消化した。そ
してフエノール抽出で除蛋白後、DNAをエタノール沈澱
として得、沈澱を10t/0.1E 7μl(〜1μg/μl)に溶
解させた。
On the other hand, 10 μg of pHBglIIcos was digested by reacting 100 μl of the reaction mixture with 94 units of BglII at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 7 µl (∼1 µg / µl).

そして、pAPcos(BglII)のcos及びTcrを含むBglII断
片のDNA溶液1μl(〜1μg)と、pHBglIIcosをBglII
で消化したDNA溶液1μl(〜1μg)とを、反応混液2
0μlで6ユニツトのT4−DNAリガーゼと12℃で17.5時間
反応させて連結した。その後、フエノール抽出を行な
い、DNAをエタノール沈澱として得、沈澱を0.1M Tris−
HCl(pH7.5)溶液20μlに溶解させた。
Then, BglII and PAPcos DNA solution 1μl of BglII fragment containing the cos and Tc r of (BglII) (~1μg), the pHBglIIcos
1 μl (~ 1 μg) of the DNA solution digested with
It was ligated by reacting with 0 μl of 6-unit T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was carried out to obtain DNA as an ethanol precipitate, and the precipitate was extracted with 0.1 M Tris-
It was dissolved in 20 μl of HCl (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、AprかつTcrクローンを得
た。次いでこれらのクローンのもつプラスミドDNAの特
性を調べて、同一の方向性を持つたcosを2個有するプ
ラスミド:pDcos Apr/Tcr(2BglII)(第6図)を持つ
大腸菌を得た。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc r clones were obtained. Then, the properties of the plasmid DNAs of these clones were examined to obtain Escherichia coli having a plasmid having two cos having the same orientation: pDcos Ap r / Tc r (2BglII) (Fig. 6).

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpDcos Apr/Tc
r(2BglII)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Ap r / Tc.
r (2BglII) plasmid DNA was prepared.

(g)pDcos Apr/Tcrの作成及び調製 pDcos Apr/Tcr(2BglII)10μgを反応混液100μl
で、11.0ユニツトのBglIIと37℃で30分間反応させて限
定消化した。次で、フエノール抽出で除蛋白後、DNAを
エタノール沈澱として得た。このDNA沈澱を反応混液100
μlで21.8ユニツトのPvuIIと37℃で2時間反応させて
完全に消化したのち、0.8%調製用アガロースゲル電気
泳動にかけて、2個のcos及びori,Apr,Tcrを含むDNA断
片(4.2Kbp)を分離精製して、DNAをエタノール沈澱と
して得、沈澱を10t/0.1E 6.5μl(〜1μg/μl)に溶
解させた。
(G) pDcos Ap r / Tc r creation and preparation pDcos Ap r / Tc r (2BglII ) 10μg reaction mixture 100μl
Then, it was reacted with 11.0 unit of BglII at 37 ° C for 30 minutes for limited digestion. Next, after deproteinizing with phenol extraction, DNA was obtained as an ethanol precipitate. This DNA precipitate is added to the reaction mixture 100
After reacting with 2 μl of 21.8 unit PvuII for 2 hours at 37 ° C for complete digestion, it was subjected to 0.8% preparative agarose gel electrophoresis and subjected to a DNA fragment containing two cos and ori, Ap r , and Tc r (4.2 Kbp). 2) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 6.5 t (0.1 μg / μl) of 10 t / 0.1E.

次に、このDNA溶液1μl(〜1μg)を、反応混液2
5μlで、2ユニツトのKlenow酵素と22℃で30分間反応
させて、cohesive endをblunt endに変えた。そして、
反応液を65℃で10分間熱処理してKlenow酵素を失活させ
た。
Next, 1 μl (~ 1 μg) of this DNA solution was added to the reaction mixture 2
5 μl was reacted with 2 units of Klenow enzyme at 22 ° C. for 30 minutes to change cohesive end to blunt end. And
The reaction solution was heat-treated at 65 ° C for 10 minutes to inactivate the Klenow enzyme.

次に、このDNA溶液10μl(0.4μg)とPvuIIリンカ
ー〔d(pC−C−A−G−C−T−G−G)〕2μgと
を、反応混液20μlで、6ユニツトのT4−DNAリガーゼ
と22℃で6時間反応させて連結した。
Next, 10 μl (0.4 μg) of this DNA solution and 2 μg of PvuII linker [d (pC-C-A-G-C-T-TG-G)] were mixed with 20 μl of a reaction mixture to prepare 6 units of T4-DNA ligase. Was reacted at 22 ° C. for 6 hours for ligation.

そして、この反応液10μlを、反応混液50μlで、15
ユニツトのT4−DNAリガーゼと12℃で17.5時間反応させ
て、2個のcos及びori,Apr,TcrからなるDNA断片(4.2K
bp)を閉環化させた。その後、フエノール抽出を行な
い、DNAをエタノール沈澱として得、沈澱を0.1M Tris−
HCl(pH7.5)溶液20μlに溶解させた。
Then, add 10 μl of this reaction solution to 50 μl of the reaction mixture,
After reacting with unit T4-DNA ligase at 12 ℃ for 17.5 hours, a DNA fragment consisting of two cos and ori, Ap r , and Tc r (4.2K
bp) was closed. Then, phenol extraction was carried out to obtain DNA as an ethanol precipitate, and the precipitate was extracted with 0.1 M Tris-
It was dissolved in 20 μl of HCl (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、AprかつTcrクローンを得
た。そして、これらのクローンのもつプラスミドDNAの
特性を調べて、pDcos Apr/Tcr(2BglII)のPvuIIサイ
トとBglIIサイトの間のDNA断片(0.2Kbp)を欠いたプラ
スミド:pDcos Apr/Tcr(第6図)を持つ大腸菌を得
た。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc r clones were obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and a plasmid lacking the DNA fragment (0.2 Kbp) between the PvuII site and the BglII site of pDcos Ap r / Tc r (2BglII): pDcos Ap r / Tc r E. coli having (Fig. 6) was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpDcos Apr/Tcr
プラスミドDNAを調製した。
This E. coli was grown in TYG-P medium 1, and ccc-DNA was separated and purified from the cells to prepare pDcos Ap r / Tc r plasmid DNA.

(h)pDcos Apr/Tcr・XhoIaの作成及び調製 pDcos Apr/Tcr 10μgを反応混液100μlで、42.9ユ
ニツトのAvaIと37℃で2時間反応させて消化した。そし
て、フエノール抽出で除蛋白後、DNAをエタノール沈澱
として得、沈澱を10t/0.1E 7μl(〜1μg/μl)に溶
解させた。
(H) in pDcos Ap r / Tc r · XhoI a creation and preparation pDcos Ap r / Tc r 10μg reaction mixture 100 [mu] l, was digested by reacting for 2 hours at 42.9 Yunitsuto of AvaI and 37 ° C.. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 7 µl (~ 1 µg / µl).

次に、このAvaIで消化したDNA溶液1μl(〜1μ
g)を、反応混液25μlで、2ユニツトのKlenow酵素と
22℃で30分間反応させて、cohesive endをblunt endに
変えた。そして反応液を65℃で10分間熱処理してKlenow
酵素を失活させた。
Next, 1 μl of DNA solution digested with this AvaI (up to 1 μl
g) in a reaction mixture of 25 μl with 2 units of Klenow enzyme
The reaction was performed at 22 ° C for 30 minutes, and the cohesive end was changed to blunt end. Then heat the reaction mixture at 65 ° C for 10 minutes and heat it to Klenow.
The enzyme was inactivated.

このDNA溶液10μl(0.4μg)と、XhoIリンカー〔d
(pC−C−T−C−G−A−G−G)〕2μgとを、反
応混液20μlで6ユニツトのT4−DNAリガーゼと22℃で
6時間反応させて連結した。その後、フエノール抽出を
行ない、DNAをエタノール沈澱として得た。
10 μl (0.4 μg) of this DNA solution and XhoI linker [d
(PC-C-T-C-G-A-G-G)] 2 μg was reacted with 6 units of T4-DNA ligase in 20 μl of the reaction mixture at 22 ° C. for 6 hours for ligation. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.

このDNA沈澱を、反応混液600μl(150mM NaCl,6mM T
ris−HCl(pH7.9)、6mM MgCl2,6mM DTT,100μg/m lBS
A)で、1000ユニツトのXhoI(New England Biolabs社
製)と37℃で4時間反応させて消化したのち、0.8%調
製用アガロースゲル電気泳動にかけて、2個のcos及びo
ri,Apr,Tcrを含むDNA断片(4.2Kbp)を分離精製して、
DNAをエタノール沈澱として得た。
This DNA precipitate was mixed with 600 μl of the reaction mixture (150 mM NaCl, 6 mM T
ris-HCl (pH 7.9), 6 mM MgCl 2 , 6 mM DTT, 100 μg / ml BS
In A), 1000 units of XhoI (manufactured by New England Biolabs) were reacted at 37 ° C. for 4 hours for digestion and then subjected to 0.8% preparative agarose gel electrophoresis to give two cos and o.
A DNA fragment (4.2 Kbp) containing ri, Ap r and Tc r is separated and purified,
DNA was obtained as an ethanol precipitate.

このDNA沈澱を反応混液20μlで、6ユニツトのT4−D
NAリガーゼと12℃で17.5時間反応させて閉環化したの
ち、フエノール抽出を行ない、DNAをエタノール沈澱と
して得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに
溶解させた。
This DNA precipitate was treated with 20 μl of the reaction mixture to prepare 6 units of T4-D.
After reaction with NA ligase at 12 ° C. for 17.5 hours for cyclization, folloWed by phenol extraction, DNA Was obtained as an ethanol precipitate, and the precipitate Was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、AprかつTcrクローンを得
た。次で、これらのクローンのもつプラスミドDNAの特
性を調べて、pDcos Apr/TcrのAvaIサイトにXhoIリンカ
ーを挿入させたプラスミド:pDcos Apr/Tcr・XhoIa(第
6図)を持つ大腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc r clones were obtained. In the next, by examining the characteristics of plasmid DNA possessed by these clones, the plasmid was inserted the XhoI linker AvaI site pDcos Ap r / Tc r: with pDcos Ap r / Tc r · XhoI a ( Figure 6) E. coli was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpDcos Apr/Tcr
XhoIaのプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Ap r / Tcr r.
XhoI a plasmid DNA was prepared.

(i)pDcos Tcrの作成及び調製 pDcos Apr/Tcr・XhoIa10μgを反応混液100μlで6.
2ユニツトのBstEIIと60℃で30分間反応させて限定消化
した。そしてフエノール抽出で除蛋白後、DNAをエタノ
ール沈澱として得、沈澱を10t/0.1 E7μl(〜1μg/μ
l)に溶解させた。
(I) pDcos Tc r creation and preparation pDcos Ap r / Tc r · XhoI a 10μg in the reaction mixture 100 [mu] l 6.
Two units of BstEII were reacted at 60 ° C for 30 minutes for limited digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1 E7 μl (~ 1 μg / μ
l).

次に、このBstEIIで限定消化したDNA溶液1μl(〜
1μg)を、反応混液25μlで、2ユニツトのKlenow酵
素と22℃で30分間反応させて、cohesive endをblunt en
dに変えた。そして反応液を65℃で10分間熱処理してKle
now酵素を失活させた。
Next, 1 μl of the DNA solution that had been digested with this BstEII (
1 μg) with 25 μl of the reaction mixture and reacted with 2 units of Klenow enzyme at 22 ° C for 30 minutes to blunt en the cohesive end.
changed to d. Then, heat the reaction solution at 65 ° C for 10 minutes to remove Kle.
now the enzyme has been deactivated.

このDNA溶液10μl(0.4μg)と、PstIリンカー〔d
(pG−C−T−G−C−−A−G−C)〕2μgとを、
反応混液20μlで6ユニツトのT4−DNAリガーゼと22℃
で6時間反応させて連結した。その後、フエノール抽出
を行ない、DNAをエタノール沈澱として得た。
10 μl (0.4 μg) of this DNA solution and PstI linker [d
(PG-C-T-G-C--A-G-C)] 2 μg,
20 μl of reaction mixture and 6 units of T4-DNA ligase and 22 ℃
Was reacted for 6 hours and ligated. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.

このDNA沈澱を、反応混液400μl(50mM(NH4)2SO4、2
0mM Tris−HCl(pH7.5)、10mM MgCl2、100μg/mlBSA)
で、600ユニツトのPstI(New England Biolabs社製)と
37℃で4時間反応させて消化したのち、0.8%調製用ア
ガロースゲル電気泳動にかけて、2個のcos及びori,Tcr
を含むDNA断片(〜4Kbp)を分離精製して、DNAをエタノ
ール沈澱として得た。
This DNA precipitate was added to 400 μl of the reaction mixture (50 mM (NH 4 ) 2 SO 4 , 2
0 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 100 μg / ml BSA)
And a 600 unit PstI (New England Biolabs)
After 4 hours reacted digested with 37 ° C., agarose gel electrophoresis 0.8% preparation, two cos and ori, Tc r
Was isolated and purified to obtain DNA as an ethanol precipitate.

次に、このDNA沈澱を反応混液20μlで、6ユニツト
のT4−DNAリガーゼと12℃で17.5時間反応させて閉環化
したのち、フエノール抽出を行ない、DNAをエタノール
沈澱として得、沈澱を0.1M Tris−HCl(pH7.5)溶液20
μlに溶解させた。
Next, this DNA precipitate was reacted with 6 μl of T4-DNA ligase at 12 ° C. for 17.5 hours for cyclization in 20 μl of the reaction mixture, followed by phenol extraction to obtain DNA as an ethanol precipitate. -HCl (pH 7.5) solution 20
It was dissolved in μl.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Tcrクローンを得た。次
いでこれらのクローンのもつプラスミドDNAの特性を調
べて、pDcos Apr/Tcr・XhoIaのBstEIIサイトとPstIサ
イトの間のDNA断片(〜0.2Kbp)を欠いたプラスミド:pD
cos Tcr(第3,6図)を持つ大腸菌を得た。なお、本菌株
は、工業技術院微生物工業技術研究所に「微工研菌第75
51号(FERMP−7551)」として寄託されている。
Then, after transforming Escherichia coli (HB101) with 10 μl of this DNA solution, a Tc r clone was obtained. Then, the characteristics of the plasmid DNA of these clones were examined, and the plasmid pDcos Ap r / Tcr r XhoI a lacking the DNA fragment (~ 0.2 Kbp) between the BstEII and PstI sites: pD
E. coli with cos Tc r (Figs. 3 and 6) were obtained. In addition, this strain was submitted to the Microtechnology Research Institute
No. 51 (FERMP-7551) "has been deposited.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpDcos Tcrのプラ
スミドDNAを調製した。
The E. coli, after grown in TYG-P medium 1, and plasmid DNA was prepared for pDcos Tc r a ccc-DNA from the cells was separated and purified.

実施例2 pDcos Tcr/oriの作成及び調製(第7図) (a)pBR−327・XhoIpの作成及び調製 pBR−327 10μgを反応混液100μlで、24.8ユニツト
のPstIと37℃で2時間反応させて消化した。そして、フ
エノール抽出で除蛋白後、DNAをエタノール沈澱として
得、沈澱を10t/0.1E 7μl(〜1μg/μl)に溶解させ
た。次に、このPstIで消化したDNA溶液1.5μl(〜1.5
μg)を、反応混液30μl(33mM Tris−aceta−te(pH
7.9)、66mM酢酸カリ、10mM MgCl2、0.5mM DTT,100μg/
me BSA、0.1mM dATP、0.1mM dCTP、0.1mM dGTP、0.1mM
dTTP)で、5ユニツトのT4−DNAポリメラーゼ(P.L社
製)と、37℃で15分間反応させて、cohesive endをblun
t endに変えた。そして、反応液を65℃で10分間熱処理
してT4−DNAポリメラーゼを失活させた。
Example In 2 pDcos Tc r / ori creation and preparation (Figure 7) (a) pBR-327 · XhoI p creation and preparation pBR-327 10 [mu] g of reaction mixture 100 [mu] l, 24.8 Yunitsuto of PstI and 37 2 hours at ℃ It was reacted and digested. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 7 µl (~ 1 µg / µl). Next, 1.5 μl of this PstI-digested DNA solution (~ 1.5
30 μl of reaction mixture (33 mM Tris-aceta-te (pH
7.9), 66 mM potassium acetate, 10 mM MgCl 2 , 0.5 mM DTT, 100 μg /
me BSA, 0.1mM dATP, 0.1mM dCTP, 0.1mM dGTP, 0.1mM
dTTP), react with 5 units of T4-DNA polymerase (manufactured by PL) at 37 ° C for 15 minutes to blun the cohesive end.
changed to t end. Then, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate T4-DNA polymerase.

このDNA溶液8μl(0.4μg)と、XhoIリンカー〔d
(pC−C−T−C−G−A−G−G)〕2μgとを、反
応混液20μlで6ユニツトのT4−DNAリガーゼと22℃で
6時間反応させて連結した。その後、フエノール抽出を
行ない、DNAをエタノール沈澱として得た。
8 μl (0.4 μg) of this DNA solution and XhoI linker [d
(PC-C-T-C-G-A-G-G)] 2 μg was reacted with 6 units of T4-DNA ligase in 20 μl of the reaction mixture at 22 ° C. for 6 hours for ligation. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.

このDNA沈澱を、反応混液600μlで1000ユニツトのXh
oIと37℃で4時間反応させて消化したのち、0.8%調製
用アガロースゲル電気泳動にかけて、3.27KbpのDNA断片
を分離精製して、DNAをエタノール沈澱として得た。
This DNA precipitate was treated with 600 μl of the reaction mixture to obtain 1000 units of Xh.
After digestion by reacting with oI for 4 hours at 37 ° C., it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify the 3.27 Kbp DNA fragment, and the DNA was obtained by ethanol precipitation.

このDNA沈澱を反応混液20μlで6ユニツトのT4−DNA
リガーゼと12℃で17.5時間反応させて閉環化したのち、
フエノール抽出を行ない、DNAをエタノール沈澱として
得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに溶解
させた。
This DNA precipitate was mixed with 20 µl of the reaction mixture to prepare 6 units of T4-DNA.
After cyclization by reacting with ligase at 12 ° C for 17.5 hours,
A DNA was obtained as an ethanol precipitate by phenol extraction, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Tcrクローンを得た。次
いでこれらのクローンのもつプラスミドDNAの特性を調
べてpBR−327のPstIサイトにXhoIリンカーを挿入させた
プラスミド:pBR−327・XhoIp(第7図)を持つ大腸菌を
得た。
Then, after transforming Escherichia coli (HB101) with 10 μl of this DNA solution, a Tc r clone was obtained. Then, the characteristics of the plasmid DNA of these clones were examined to obtain Escherichia coli harboring the plasmid: pBR-327.XhoI p (Fig. 7) in which the XhoI linker was inserted into the PstI site of pBR-327.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpBR−327・XhoIp
のプラスミドDNAを調製した。
This E. coli was grown in TYG-P medium 1, and ccc-DNA was separated and purified from the cells to obtain pBR-327.XhoI p.
Was prepared.

(b)pDcos Tcr(2ori)の作成及び調製 pDcos Tcr20μgを、反応混液500μl(150mM NaCl、
6mM Tris−HCl(pH7.9)、6mM MgCl2,6mM DTT,100μg/m
l BSA)で、167ユニツトの制限酵素BamHI(New England
Biolabs社製)及び500ユニツトのXhoIと37℃で2時間
反応させて完全に消化したのち、0.8%調製用アガロー
スゲル電気泳動にかけて、2個のcos及びoriを含むDNA
断片(2.4Kbp)を分離精製して、DNAをエタノール沈澱
として得、沈澱を10t/0.1E 9.5μl(〜1μg/μl)に
溶解させた。
(B) Preparation and preparation of pDcos Tc r (2ori) 20 μg of pDcos Tc r was added to 500 μl of the reaction mixture (150 mM NaCl,
6mM Tris-HCl (pH7.9), 6mM MgCl 2, 6mM DTT, 100μg / m
l BSA), 167 unit restriction enzyme BamHI (New England
Biolabs) and 500 units of XhoI at 37 ° C for 2 hours for complete digestion, and then 0.8% preparative agarose gel electrophoresis for DNA containing two cos and ori.
The fragment (2.4 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 9.5 μl of 10 t / 0.1E (˜1 μg / μl).

一方、pBR−327 XhoIp 20μgを反応混液500μlで、
167ユニツトのBamHI及び500ユニツトのXhoIと37℃で2
時間反応させて完全に消化したのち、0.8%調製用アガ
ロースゲル電気泳動にかけて、oriを含むDNA断片(2.14
Kbp)を分離精製して、DNAをエタノール沈澱として得、
沈澱を10t/0.1E 9.0μl(〜1μg/μl)に溶解させ
た。
On the other hand, 20 μg of pBR-327 XhoI p in 500 μl of the reaction mixture,
167 units of BamHI and 500 units of XhoI at 37 ℃
After reacting for a period of time to complete digestion, 0.8% preparative agarose gel electrophoresis was performed and the DNA fragment containing ori (2.14
Kbp) is separated and purified to obtain DNA as an ethanol precipitate,
The precipitate was dissolved in 9.0 t of 10 t / 0.1E (-1 g / l).

そして、pDcos Tcrのcos及びoriを含むBamHI/XhoI断
片のDNA溶液1μl(〜1μg)と、pBR−327・XhoIp
oriを含むBamHI/XhoI断片のDNA溶液1μl(〜1μg)
とを、反応混液20μlで6ユニツトのT4−DNAリガーゼ
と12℃で17.5時間反応させて連結した。その後、フエノ
ール抽出を行ない、DNAをエタノール沈澱として得、沈
澱を0.1M Tris−HCl(pH7.5)溶液20μlに溶解させ
た。
Then, the BamHI / XhoI fragment containing the cos and ori of pDcos Tc r a DNA solution 1μl (~1μg), the pBR-327 · XhoI p
DNA solution of BamHI / XhoI fragment containing ori 1 μl (~ 1 μg)
Were ligated by reacting 20 units of the reaction mixture with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、Tcrクローンを得た。次い
でこれらのクローンのもつプラスミドDNAの特性を調べ
て、2個のcos及び2個のori,Tcrを有するプラスミド:p
Dcos Tcr(2ori)(第7図)を持つ大腸菌を得た。
Then, after transforming E. coli (HB101) with 10 μl of this DNA solution, a Tc r clone was obtained. Then examine the characteristics of plasmid DNA possessed by these clones, two cos and two ori, plasmid has a Tc r: p
It was obtained Dcos Tc r (2ori) E. coli with (Figure 7).

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpDcos Tcr(2or
i)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Tc r (2or
The plasmid DNA of i) was prepared.

(c)pSV2−dhfrΔ(BglII)の作成及び調製 pSV2−dhfr〔Subramani,Mulligan & Berg,Mol.Cell.
Biol.,1,854(1981)〕10μgを反応混液100μlで、4
8.5ユニツトのBglIIと37℃で2時間反応させて消化し
た。そして、フエノール抽出で除蛋白後、DNAをエタノ
ール沈澱として得、沈澱を10t/0.1E 7μl(〜1μg/μ
l)に溶解させた。
(C) Construction and preparation of pSV2-dhfrΔ (BglII) pSV2-dhfr [Subramani, Mulligan & Berg, Mol. Cell.
Biol., 1 , 854 (1981)] 10 μg in 100 μl of reaction mixture,
It was digested by reacting with 8.5 unit BglII at 37 ° C for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1E 7 µl (~ 1 µg / µ
l).

次に、このBglIIで消化したDNA溶液1μl(〜1μ
g)を、反応混液25μlで、2ユニツトのKlenow酵素と
22℃で30分間反応させて、cohesive endをblunt endに
変えた。そして反応液を65℃で10分間熱処理してKlenow
酵素を失活させた。
Next, 1 μl of the DNA solution digested with this BglII (up to 1 μl
g) in a reaction mixture of 25 μl with 2 units of Klenow enzyme
The reaction was performed at 22 ° C for 30 minutes, and the cohesive end was changed to blunt end. Then heat the reaction mixture at 65 ° C for 10 minutes and heat it to Klenow.
The enzyme was inactivated.

次に、このDNA溶液10μl(〜0.4μg)を反応混液50
μlで、15ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて閉環化したのち、フエノール抽出を行な
い、DNAをエタノール沈澱として得、沈澱を0.1M Tris−
HCl(pH7.5)溶液20μlに溶解させた。
Next, add 10 μl (~ 0.4 μg) of this DNA solution to the reaction mixture 50
After cyclization with 15 μl of T4-DNA ligase (15 units) at 12 ° C. for 17.5 hours, folloWed by phenol extraction, the DNA Was obtained as an ethanol precipitate.
It was dissolved in 20 μl of HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Aprクローンを得た。次
いで、これらのクローンのもつプラスミドDNAの特性を
調べて、pSV2−dhfrのBglIIサイトを欠いたプラスミド:
pSV2−dhfrΔ(BglII)(第7図)を持つ大腸菌を得
た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Then, the characteristics of the plasmid DNA of these clones were examined to find a plasmid lacking the BglII site of pSV2-dhfr:
Escherichia coli having pSV2-dhfrΔ (BglII) (Fig. 7) was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpSV2−dhfrΔ(Bg
lII)のプラスミドDNAを調製した。
This E. coli was grown in TYG-P medium 1, and ccc-DNA was separated and purified from the cells to obtain pSV2-dhfrΔ (Bg
lII) plasmid DNA was prepared.

(d)pDcos Tcr/oriの作成及び調製 pDcos Tcr(2ori)20μgを反応混液500μl〔60mM N
aCl,6mM Tris−HCl(pH7.5)、6mM MgCl2、6mM DTT,100
μg/ml BSA〕で、42.5ユニツトのPvuII及び35.8ユニツ
トのPstIと37℃で2時間反応させて完全に消化したの
ち、0.8%調製用アガロースゲル電気泳動にかけて、2
個のcos及びori,Tcrを含むDNA断片(3.1Kbp)を分離精
製して、DNAをエタノール沈澱として得、沈澱を10t/0.1
E 9.5μl(〜1μg/μl)に溶解させた。
(D) Preparation and preparation of pDcos Tc r / ori 20 μg of pDcos Tc r (2ori) was added to the reaction mixture 500 μl [60 mM N
aCl, 6mM Tris-HCl (pH7.5 ), 6mM MgCl 2, 6mM DTT, 100
μg / ml BSA] with PvuII (42.5 units) and PstI (35.8 units) at 37 ° C. for 2 hours for complete digestion, followed by 0.8% preparative agarose gel electrophoresis.
Number of cos and ori, was separated and purified DNA fragment (3.1 kbp) containing the Tc r, to obtain a DNA as ethanol precipitation, the precipitate 10t / 0.1
It was dissolved in 9.5 μl of E (˜1 μg / μl).

一方、pSV2−dhfrΔ(BglII)20μgを反応混液500μ
lで、38.8ユニツトのPvuII及び32.7ユニツトのPstIと3
7℃で2時間反応させて完全に消化したのち、0.8%調製
用アガロースゲル電気泳動にかけて、SV−dhfrを含むDN
A断片(2.45Kbp)を分離精製して、DNAをエタノール沈
澱として得、沈澱を10t/0.1E 7μl(〜1μg/μl)に
溶解させた。
On the other hand, add 20 μg of pSV2-dhfrΔ (BglII) to the reaction mixture 500 μm.
1 with 38.8 unit PvuII and 32.7 unit PstI and 3
After 2 hours of reaction at 7 ℃ for complete digestion, 0.8% preparative agarose gel electrophoresis was performed to obtain DN containing SV-dhfr.
The A fragment (2.45 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 7 μl of 10 t / 0.1E (˜1 μg / μl).

そして、pDcos Tcr(2ori)のcos及びori,Tcrを含むP
vuII/PstI断片のDNA溶液1μl(〜1μg)と、pSV2−
dhfrΔ(BglII)のSV−dhfrを含むPvuII/PstI断片のDNA
溶液1μl(〜1μg)とを、反応混液20μlで6ユニ
ツトのT4−DNAリガーゼと12℃で17.5時間反応させて連
結した。その後、フエノール抽出を行ない、DNAをエタ
ノール沈澱として得、沈澱を0.1M Tris−HCl(pH7.5)
溶液20μlに溶解させた。
Then, P including cos and ori, Tc r of pDcos Tc r (2ori)
1 μl (~ 1 μg) DNA solution of vuII / PstI fragment and pSV2-
DNA of PvuII / PstI fragment containing SV-dhfr of dhfrΔ (BglII)
1 μl of the solution (˜1 μg) was ligated by reacting 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was extracted with 0.1 M Tris-HCl (pH 7.5).
It was dissolved in 20 μl of the solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、Tcrクローンを得た。次い
で、これらのクローンのもつプラスミドDNAの特性を調
べて、2個のcos及びori,Tcr,SV−dhfrを有するプラス
ミド:pDcos Tcr/ori(第4、7図)を持つ大腸菌を得
た。なお、本菌株は、工業技術院微生物工業技術研究所
に「微工研菌第7554号(FERMD−7554)」として寄託さ
れている。
Then, after transforming E. coli (HB101) with 10 μl of this DNA solution, a Tc r clone was obtained. Then, by examining the characteristics of plasmid DNA possessed by these clones, two cos and ori, Tc r, plasmids having a SV-dhfr: pDcos Tc r / ori ( 4th and 7th Figure) to give E. coli with . In addition, this strain has been deposited at the Institute of Microbial Science and Technology, the Agency of Industrial Science and Technology, as “Microindustrial Research Institute No. 7554 (FERMD-7554)”.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Tcr/ori
のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells, and pDcos Tc r / ori
Was prepared.

実施例3 pDcos Apr/oriの作成及び調製(第8図) (a)pBR−327 XhoIaの作成及び調製 pBR−32710μgを反応混液100μlで、110ユニツトの
AvaIと37℃で2時間反応させて消化した。そして、フエ
ノール抽出で除蛋白後、DNAをエタノール沈澱として
得、沈澱を10t/0.1E 7μl(〜1μg/μl)に溶解させ
た。
Example 3 Preparation and Preparation of pDcos Ap r / ori (FIG. 8) (a) Preparation and Preparation of pBR-327 XhoI a 10 μg of pBR-327 in 100 μl of the reaction mixture was added to 110 units of 110 units.
It was digested by reacting with AvaI at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 7 µl (~ 1 µg / µl).

次に、このAvaIで消化したDNA溶液1μl(〜1μ
g)を、反応混液25μlで、2ユニツトのKlenow酵素と
22℃で30分間反応させて、cohesive endをblunt endに
変えた。そして、反応液を65℃で10分間熱処理してKlen
ow酵素を失活させた このDNA溶液10μl(0.4μg)と、XhoIリンカー〔d
(pC−C−T−C−G−A−G−G)〕2μgとを、反
応混液20μlで6ユニツトのT4−DNAリガーゼと22℃で
6時間反応させて連結した。その後、フエノール抽出を
行ない、DNAをエタノール沈澱として得た。
Next, 1 μl of DNA solution digested with this AvaI (up to 1 μl
g) in a reaction mixture of 25 μl with 2 units of Klenow enzyme
The reaction was performed at 22 ° C for 30 minutes, and the cohesive end was changed to blunt end. Then, heat the reaction solution at 65 ° C. for 10 minutes and then use Klen.
ow enzyme inactivated 10 μl (0.4 μg) of this DNA solution and XhoI linker [d
2 μg of (pC-C-T-C-G-A-G-G)] was ligated with 20 μl of the reaction mixture by reacting with 6 units of T4-DNA ligase at 22 ° C. for 6 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.

このDNA沈澱を、反応混液600μlで、1000ユニツトの
XhoIと37℃で4時間反応させて消化したのち、0.8%調
製用アガロースゲル電気泳動にかけて、3.27KbpのDNA断
片を分離精製して、DNAをエタノール沈澱として得た。
This DNA precipitate was treated with 600 μl of the reaction mixture to obtain 1000 units of
After digestion by reacting with XhoI for 4 hours at 37 ° C., it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify the 3.27 Kbp DNA fragment, and the DNA was obtained by ethanol precipitation.

このDNA沈澱を反応混液20μlで6ユニツトのT4−DNA
リガーゼと12℃で17.5時間反応させて閉環化したのち、
フエノール抽出を行ない、DNAをエタノール沈澱として
得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに溶解
させた。
This DNA precipitate was mixed with 20 µl of the reaction mixture to prepare 6 units of T4-DNA.
After cyclization by reacting with ligase at 12 ° C for 17.5 hours,
A DNA was obtained as an ethanol precipitate by phenol extraction, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、AprかつTcrクローンを得
た。次いで、これらのクローンのもつプラスミドDNAの
特性を調べて、pBR−327のAvaIサイトにXhoIリンカーを
挿入させたプラスミド:pBR−327・XhoIa(第8図)を持
つ大腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc r clones were obtained. Then, by examining the characteristics of plasmid DNA possessed by these clones, the plasmid was inserted the XhoI linker AvaI site of pBR-327: pBR-327 · XhoI a ( Figure 8) to give E. coli with.

この大腸菌をTYG−P培地1中で増殖させたのち、
菌体よりccc−DNAを分離精製して、pBR−327・XhoIa
プラスミドDNAを調製した。
After growing this E. coli in TYG-P medium 1,
The ccc-DNA from the cells was separated and purified, and plasmid DNA was prepared in pBR-327 · XhoI a.

(b)pDcos Apr/ori/dhfrΔ(BglII)の作成及び調製 pDcos Tcr/ori 20μgを反応混液200μlで106ユニツ
トのEcoRIと37℃で2時間反応させて消化したのちさら
に反応混液500μlで530ユニツトのXhoIと37℃で2時間
反応させて消化した。その後、0.8%調製用アガロース
ゲル電気泳動にかけて2個のcos及びSV−dhfrを含むDNA
断片(〜2.9Kbp)を分離精製して、DNAをエタノール沈
澱として得、沈澱を10t/0.1E 7μl(〜1μg/μl)に
溶解させた。
(B) Preparation and preparation of pDcos Ap r / ori / dhfrΔ (BglII) 20 μg of pDcos Tc r / ori was reacted with 200 μl of the reaction mixture for 2 hours at 37 ° C. with 106 units of EcoRI, and then digested with 500 μl of the reaction mixture for 530 It was digested by reacting with XhoI of unit at 37 ° C. for 2 hours. Then, it was subjected to 0.8% preparative agarose gel electrophoresis and the DNA containing two cos and SV-dhfr.
The fragment (~ 2.9 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 7 µl of 10t / 0.1E (~ 1 µg / µl).

一方、pBR−327・XhoIa 20μgを反応混液200μlで1
67ユニツトのEcoRIと37℃で2時間反応させて消化した
のち、さらに反応混液500μlで880ユニツトのXhoIと37
℃で2時間消化した。その後、0.8%調製用アガロース
ゲル電気泳動にかけて、ori及びAprを含むDNA断片(1.8
4Kbp)を分離精製して、DNAをエタノール沈澱として
得、沈澱を10t/0.1E 8μl(〜1μg/μl)に溶解させ
た。
On the other hand, 20 μg of pBR-327 / XhoI a was added to 200 μl of the reaction mixture to prepare 1
After digesting with 67 units of EcoRI for 2 hours at 37 ℃, 500 μl of the reaction mixture was added to 880 units of XhoI and 37
Digested at ℃ for 2 hours. Then, it was subjected to 0.8% preparative agarose gel electrophoresis, and a DNA fragment containing ori and Ap r (1.8
4 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 8 μl of 10 t / 0.1E (˜1 μg / μl).

そして、pDcos Tcr/oriのcos及びSV−dhfrを含むEcoR
I/XhoI断片のDNA溶液1μl(〜1μg)と、pBR−327
・XhoIaのori及びAprを含むEcoRI/XhoI断片のDNA溶液1
μl(〜1μg)とを、反応混液20μlで6ユニツトの
T4−DNAリガーゼと12℃で17.5時間反応させて連結し
た。その後、フエノール抽出を行ない、DNAをエタノー
ル沈澱として得、沈澱を0.1M Tris−HCl(pH7.5)溶液2
0μlに溶解させた。
And EcoR including pDcos Tc r / ori cos and SV-dhfr
1 μl (~ 1 μg) DNA solution of I / XhoI fragment and pBR-327
・ DNA solution 1 of EcoRI / XhoI fragment containing ori and Ap r of XhoI a
μl (~ 1 μg) and 20 μl of reaction mixture
Ligation was performed by reacting with T4-DNA ligase at 12 ° C for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 2
It was dissolved in 0 μl.

次に、このDNA溶液10μlで大腸菌(HB101)とトラン
スホーメーシヨンしたのち、Aprクローンを得た。次い
で、これらのクローンのもつプラスミドDNAの特性を調
べて、2個のcos及びori,Apr,SV−dhfrΔ(BglII)を有
するプラスミド:pDcos Apr/ori/dhfrΔ(BglII)(第8
図)を持つ大腸菌を得た。
Next, 10 μl of this DNA solution was transformed with Escherichia coli (HB101) to obtain Ap r clone. Then, the characteristics of the plasmid DNA of these clones were examined to find a plasmid having two cos and ori, Ap r , SV-dhfrΔ (BglII): pDcos Ap r / ori / dhfrΔ (BglII) (8th
E. coli having (Fig.) Was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Apr/ori/
dhfrΔ(BglII)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Ap r / ori /
A dhfrΔ (BglII) plasmid DNA was prepared.

(c)pSV2−dhfrΔ(BamHI/BglII)の作成及び調製 pSV2−dhfr 10μgを反応混液100μlで48.5ユニツト
のBglIIと37℃で2時間反応させて消化したのち、さら
に反応混液250μlで58.2ユニツトのBamHIと2時間反応
させて消化した。そして、フエノール抽出で除蛋白後、
DNAをエタノール沈澱として得、沈澱を10t/0.1E 7μl
(〜1μg/μl)に溶解させた。
(C) Preparation and preparation of pSV2-dhfrΔ (BamHI / BglII) 10 μg of pSV2-dhfr was reacted with 48.5 units of BglII in 100 μl of reaction mixture at 37 ° C. for 2 hours for digestion, and further with 250 μl of reaction mixture, 58.2 units of BamHI. And reacted for 2 hours for digestion. And after deproteinizing with phenol extraction,
The DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1E 7 μl
(˜1 μg / μl).

次に、このBglIIとBamHIで消化したDNA溶液1μl
(〜1μg)を、反応混液25μlで、2ユニツトのKlen
ow酵素と22℃で30分間反応させてcohesive endをblunt
endに変えた。そして、反応液を65℃で10分間熱処理し
て、Klenow酵素を失活させた。
Next, 1 μl of this DNA solution digested with BglII and BamHI
(~ 1 μg) in 25 μl of reaction mixture, 2 units of Klen
blunt cohesive end by reacting with ow enzyme for 30 minutes at 22 ℃
I changed it to end. Then, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate the Klenow enzyme.

次に、このDNA溶液10μl(〜0.4μg)を反応混液50
μlで、15ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて閉環化したのち、フエノール抽出を行な
い、DNAをエタノール沈澱として得、沈澱を0.1M Tris−
HCl(pH7.5)溶液20μlに溶解させた。
Next, add 10 μl (~ 0.4 μg) of this DNA solution to the reaction mixture 50
After cyclization with 15 μl of T4-DNA ligase (15 units) at 12 ° C. for 17.5 hours, folloWed by phenol extraction, the DNA Was obtained as an ethanol precipitate.
It was dissolved in 20 μl of HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Aprクローンを得た。次
でこれらのクローンのもつプラスミドDNAの特性を調べ
て、pSV2−dhfrのBglIIサイトとBamHIサイトとの間のDN
A断片(0.85Kbp)を欠いたプラスミド:pSV2−dhfrΔ(B
amHI/BglII)(第8図)を持つ大腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Next, the characteristics of the plasmid DNA possessed by these clones were examined, and the DN between the BglII site and the BamHI site of pSV2-dhfr was examined.
Plasmid lacking A fragment (0.85 Kbp): pSV2-dhfrΔ (B
Escherichia coli having amHI / BglII) (Fig. 8) was obtained.

この大腸菌をTYG−P培地1中で増殖させたのち、
菌体よりccc−DNAを分離精製して、pSV2−dhfrΔ(BamH
I/BglII)のプラスミドDNAを調製した。
After growing this E. coli in TYG-P medium 1,
Ccc-DNA was separated and purified from the cells and pSV2-dhfrΔ (BamH
I / BglII) plasmid DNA was prepared.

(d)pDcos Apr/ori/dhfrΔ(BamHI/BglII)の作成及
び調製 pDcos Apr/ori/dhfrΔ(BglII)20μgを反応混液200
μlで、2.9ユニツトのPstIと37℃で30分間反応させて
限定消化した。次いでフエノール抽出で除蛋白後、DNA
をエタノール沈澱として得た。
(D) Preparation and preparation of pDcos Ap r / ori / dhfrΔ (BamHI / BglII) 20 μg of pDcos Ap r / ori / dhfrΔ (BglII) was added to the reaction mixture 200
μl was used to react with 2.9 units of PstI at 37 ° C. for 30 minutes for limited digestion. Next, deproteinize by phenol extraction, then DNA
Was obtained as an ethanol precipitate.

このDNA沈澱を反応混液200μlで34.0ユニツトのPvuI
Iと37℃で2時間反応させて消化した。その後、0.8%調
製用アガロースゲル電気泳動にかけて、2個のcos及びo
ri,Aprを含むDNA断片(2.3Kbp)を分離精製して、DNAを
エタノール沈澱として得、沈澱を10t/0.1E 7μl(〜1
μg/μl)に溶解させた。
This DNA precipitate was mixed with 200 μl of the reaction mixture to obtain 34.0 units of PvuI.
It was digested by reacting with I at 37 ° C. for 2 hours. Then, it was subjected to 0.8% preparative agarose gel electrophoresis, and two cos and o
The DNA fragment (2.3 Kbp) containing ri and Ap r was separated and purified to obtain the DNA as an ethanol precipitate. The precipitate was 10 t / 0.1E 7 μl (~ 1
μg / μl).

一方、pSV2−dhfrΔ(BamHI/BglII)20μgを反応混
液500μlで、46.8ユニツトのPvuII及び39.5ユニツトの
PstIと37℃で2時間反応させて完全に消化したのち、0.
8%調製用アガロースゲル電気泳動にかけて、SV−dhfr
を含むDNA断片(1.61Kb)を分離精製して、DNAをエタノ
ール沈澱として得、沈澱を10t/0.1E 5.5μl(〜1μg/
μl)に溶解させた。
On the other hand, 20 μg of pSV2-dhfrΔ (BamHI / BglII) was mixed with 500 μl of the reaction mixture to obtain 46.8 units of PvuII and 39.5 units of PvuII.
After reacting with PstI at 37 ℃ for 2 hours to completely digest it,
SV-dhfr was subjected to 8% preparative agarose gel electrophoresis.
A DNA fragment (1.61 Kb) containing DNA was isolated and purified to obtain DNA as an ethanol precipitate.
μl).

そして、pDcos Apr/ori/dhfrΔ(BglII)のcos及びor
i,Aprを含むPvuII/PstI断片のDNA溶液1μl(〜1μ
g)と、pSV2−dhfrΔ(BamHI/BglII)のSV−dhfrを含
むPvuII/PstI断片のDNA溶液1μl(〜1μg)とを反
応混液20μlで6ユニツトのT4−DNAリガーゼと12℃で1
7.5時間反応させて連結した。その後、フエノール抽出
を行ない、DNAをエタノール沈澱として得、沈澱を0.1M
Tris−HCl(pH7.5)溶液20μlに溶解させた。
Then, the cos and or of pDcos Ap r / ori / dhfrΔ (BglII)
1 μl of DNA solution of PvuII / PstI fragment containing i and Ap r (~ 1 μm
g) and 1 μl (to 1 μg) of a DNA solution of a PvuII / PstI fragment containing SV-dhfr of pSV2-dhfrΔ (BamHI / BglII) in a reaction mixture of 20 μl and 6 units of T4-DNA ligase at 12 ° C.
The reaction was carried out for 7.5 hours to ligate. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.
It was dissolved in 20 μl of Tris-HCl (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、Aprクローンを得た。次い
で、これらのクローンのもつプラスミドDNAの特性を調
べて、2個のcos及びori,Apr,SV−dhfrΔ(BamHI/BglI
I)を有するプラスミド:pDcos Apr/ori/dhfrΔ(BamHI/
BglII)(第8図)を持つ大腸菌を得た。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r clone was obtained. Next, the characteristics of the plasmid DNA possessed by these clones were examined, and two cos and ori, Ap r , SV-dhfrΔ (BamHI / BglI
I) -containing plasmid: pDcos Ap r / ori / dhfrΔ (BamHI /
BglII) (FIG. 8) was obtained.

この大腸菌を、TYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Apr/ori/
dhfrΔ(BamHI/BglII)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells, and pDcos Ap r / ori /
A plasmid DNA of dhfrΔ (BamHI / BglII) was prepared.

(e)pDcos Apr/ori/dhfrΔ(BamHI)の作成及び調製 pDcos Apr/ori/dhfrΔ(BamHI/BglII)10μgを、反
応混液100μlで、73.7ユニツトのEcoRIと37℃で2時間
反応させて消化した。そして、フエノール抽出で除蛋白
後、DNAをエタノール沈澱として得、沈澱を10t/0.1E 7
μl(〜1μg/μl)に溶解させた。
(E) pDcos Ap r / ori / Create dhfrΔ (BamHI) and Preparation pDcos Ap r / ori / dhfrΔ the (BamHI / BglII) 10μg, the reaction mixture 100 [mu] l, was reacted for 2 hours with EcoRI and 37 ° C. of 73.7 Yunitsuto Digested. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was extracted with 10 t / 0.1E 7
It was dissolved in μl (˜1 μg / μl).

次に、このEcoRIで消化したDNA溶液1μl(〜1μ
g)を、反応混液25μlで、2ユニツトのKlenow酵素と
22℃で30分間反応させて、cohesive endをblunt endに
変えた。そして、反応液を65℃で10分間熱処理してKlen
ow酵素を失活させた。
Next, 1 μl of this DNA solution digested with EcoRI (up to 1 μl
g) in a reaction mixture of 25 μl with 2 units of Klenow enzyme
The reaction was performed at 22 ° C for 30 minutes, and the cohesive end was changed to blunt end. Then, heat the reaction solution at 65 ° C. for 10 minutes and then use Klen.
ow The enzyme is inactivated.

このDNA溶液10μl(0.4μg)と、BamHIリンカー
〔d(pC−G−G−A−T−C−C−G)〕2μgとを
反応混液20μlで6ユニツトのT4−DNAリガーゼと22℃
で6時間反応させて連結した。その後、フエノール抽出
を行ないDNAをエタノール沈澱として得た。
10 .mu.l (0.4 .mu.g) of this DNA solution and 2 .mu.g of BamHI linker [d (pC-G-G-A-T-C-C-G)] in 20 .mu.l of reaction mixture were mixed with 6 units of T4-DNA ligase and 22.degree.
Was reacted for 6 hours and ligated. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.

このDNA沈澱を、反応混液600μlで1000ユニツトのBa
mHIと37℃で4時間反応させて消化したのち、0.8%調製
用アガロースゲル電気泳動にかけて、3.91KbpのDNA断片
を分離精製して、DNAをエタノール沈澱として得た。
This DNA precipitate was mixed with 600 μl of the reaction mixture to obtain 1000 units of Ba.
After digestion by reacting with mHI at 37 ° C. for 4 hours, it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify the 3.91 Kbp DNA fragment, and the DNA was obtained by ethanol precipitation.

このDNA沈澱を反応混液20μlで6ユニツトのT4−DNA
リガーゼと12℃で17.5時間反応させて閉環化したのち、
フエノール抽出を行ない、DNAをエタノール沈澱として
得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに溶解
させた。
This DNA precipitate was mixed with 20 µl of the reaction mixture to prepare 6 units of T4-DNA.
After cyclization by reacting with ligase at 12 ° C for 17.5 hours,
A DNA was obtained as an ethanol precipitate by phenol extraction, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Aprクローンを得た。次
いで、これらのクローンのもつプラスミドDNAの特性を
調べて、pDcos Apr/ori/dhfrΔ(BamHI/BglII)のEcoRI
サイトにBamHIリンカーを挿入させたプラスミド(この
場合、BamHIサイトの両側にEcoRIサイトが再構成され
る):pDcos Apr/ori/dhfr(BamHI)(第8図)を持つ大
腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Next, the characteristics of plasmid DNA possessed by these clones were examined, and EcoRI of pDcos Ap r / ori / dhfrΔ (BamHI / BglII) was examined.
A plasmid having a BamHI linker inserted into the site (in this case, EcoRI sites are reconstituted on both sides of the BamHI site): pDcos Ap r / ori / dhfr (BamHI) (Fig. 8) was obtained.

この大腸菌を、TYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Apr/ori/
dhfr(BamHI)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells, and pDcos Ap r / ori /
A dhfr (BamHI) plasmid DNA was prepared.

(f)pSVO10/neorの作成及び調製 pAO43(Oka,Sugisaki & Takanami,J.Mol,Biol,147,2
14(1981))20μgを反応混液200μl(60mM NaCl,6mM
Tris−HCl(pH8.0),10mM MgCl2,6mM DTT,100μg/ml B
SA)で、150ユニツトの制限酵素AvaII(New England Bi
olabs社製)と37℃で2時間反応させて消化したのち、
0.8%調製用アガロースゲル電気泳動にかけて、neor
含むDNA断片(1.24Kbp)を分離精製して、DNAをエタノ
ール沈澱として得、沈澱を10t/0.1E 5μl(〜1μg/μ
l)に溶解させた。
(F) pSVO10 / neo r of creation and preparation pAO43 (Oka, Sugisaki & Takanami, J.Mol, Biol, 147, 2
14 (1981)) 20 μg reaction mixture 200 μl (60 mM NaCl, 6 mM
Tris-HCl (pH8.0), 10 mM MgCl 2 , 6 mM DTT, 100 μg / ml B
SA), a 150-unit restriction enzyme AvaII (New England Bi
(Olabs) and digest at 37 ℃ for 2 hours,
The DNA fragment containing neo r (1.24 Kbp) was separated and purified by 0.8% preparative agarose gel electrophoresis to obtain DNA as an ethanol precipitate, and the precipitate was 10 t / 0.1E 5 μl (~ 1 μg / μ).
l).

このDNA溶液2μl(〜2μg)を、反応混液50μl
で、4ユニツトのKlenow酵素と22℃で30分間反応させ
て、cohesive endをblunt endに変えた。そして、フエ
ノール抽出で除蛋白後、DNAをエタノール沈澱として
得、沈澱を10t/0.1E 1.5μl(〜1μg/μl)に溶解さ
せた。
2 μl (~ 2 μg) of this DNA solution, 50 μl of reaction mixture
Then, it was reacted with 4 units of Klenow enzyme at 22 ° C. for 30 minutes to change the cohesive end to blunt end. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 1.5 μl (˜1 μg / μl).

一方、pSVO10〔{πVX〔Brain seed,Nucleic Acids R
es.,11,2427(1983)〕由来のポリリンカーを持つたpSV
O1〔Tjan,R,et al,Proc,Natl,Acad.Sci.U.S.A.,77,6491
(1980)〕の類縁プラスミド}〕10μgを、反応混液10
0μlで129ユニツトのBamHIと37℃で2時間反応させて
消化したのち、フエノール抽出を行ない、DNAをエタノ
ール沈澱として得、沈澱を10t/0.1E 7μl(〜1μg/μ
l)に溶解させた。
On the other hand, pSVO10 〔{πVX 〔Brain seed, Nucleic Acids R
es., 11 , 2427 (1983)] with polylinker pSV
O1 〔Tjan, R, et al, Proc, Natl, Acad.Sci.USA, 77 , 6491
(1980)] related plasmid}] 10 μg in a reaction mixture 10
After digestion with 0 µl of BamHI of 129 units for 2 hours at 37 ° C, phenol extraction was performed to obtain DNA as ethanol precipitate. The precipitate was 10 t / 0.1E 7 µl (~ 1 µg / µl).
l).

このDNA溶液2μl(〜2μg)を、反応混液50μl
で、4ユニツトのKlenow酵素と22℃で30分間反応させ
て、cohesive endをblunt endに変えた。そして、フエ
ノール抽出で除蛋白後、DNAをエタノール沈澱として
得、沈澱を10t/0.1E 1.5μl(〜1μg/μl)に溶解さ
せた。
2 μl (~ 2 μg) of this DNA solution, 50 μl of reaction mixture
Then, it was reacted with 4 units of Klenow enzyme at 22 ° C. for 30 minutes to change the cohesive end to blunt end. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 1.5 μl (˜1 μg / μl).

次に、pAO43のneorを含むDNA断片をKlenow酵素で処理
したDNA溶液1μl(〜1μg)と、pSVO10をBamHIで消
化し、Klenow酵素で処理したDNA溶液1μl(〜1μ
g)とを、反応液20μlで6ユニツトのT4−DNAリガー
ゼと12℃で17.5時間反応させて連結した。その後、フエ
ノール抽出を行ない、DNAをエタノール沈澱として得、
沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに溶解させ
た。
Next, 1 μl (~ 1 μg) of a DNA solution obtained by treating a DNA fragment containing neo r of pAO43 with Klenow enzyme and 1 μl (~ 1 μg of a DNA solution obtained by digesting pSVO10 with BamHI and treating with Klenow enzyme).
g) was ligated by reacting 20 μl of the reaction solution with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as ethanol precipitate,
The precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、AprかつKmr(neor)クロ
ーンを得た。次いでこれらのクローンをもつプラスミド
DNAの特性を調べてpSVO10のBamHIサイトにneorを挿入さ
せたプラスミド:pSVO10/neor(第8図)を持つ大腸菌を
得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Km r (neo r ) clones were obtained. Then a plasmid carrying these clones
The characteristics of the DNA were examined to obtain Escherichia coli harboring a plasmid: pSVO10 / neo r (Fig. 8) in which neo r was inserted into the BamHI site of pSVO10.

この大腸菌を、TYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製して、pSVO10/neor
プラスミドDNAを調製した。
The E. coli, in TYG-P medium 1, then grown, the ccc-DNA from the cells was separated and purified, and plasmid DNA was prepared for pSVO10 / neo r.

(g)pBR−322/neorの作成及び調製 pSVO10/neor 20μgを反応混液200μlで46.6ユニツ
トのPstIと37℃で2時間反応させて消化したのち、さら
に反応混液500μlで166ユニツトのEcoRIと37℃で2時
間反応させて消化した。その後、0.8%調製用アガロー
スゲル電気泳動にかけて、neorを含むDNA断片(1.24Kb
p)を分離精製して、DNAをエタノール沈澱として得、沈
澱を10t/0.1E 5μl(〜1μg/μl)に溶解させた。
(G) pBR-322 / neo r creation and preparation pSVO10 / neo r 20μg an after digestion by 2 hours with PstI and 37 ° C. 46.6 Yunitsuto reaction mixture 200 [mu] l, and EcoRI further reaction mixture 500μl in 166 Yunitsuto It was digested by reacting at 37 ° C for 2 hours. Then, it was subjected to 0.8% preparative agarose gel electrophoresis, and the DNA fragment containing neo r (1.24 Kb
p) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 5 μl of 10 t / 0.1E (˜1 μg / μl).

一方、pBR−322 20μgを反応混液200μlで37.2ユニ
ツトのPstIと37℃で2時間反応させて消化したのち、さ
らに反応混液500μlで132ユニツトのEcoRIと2時間反
応させて消化した。その後、0.8%調製用アガロースゲ
ル電気泳動にかけて、ori及びTcrを含むDNA断片(3.6Kb
p)を分離精製して、DNAをエタノール沈澱として得、沈
澱を10t/0.1E 11μl(〜1μg/μl)に溶解させた。
On the other hand, 20 µg of pBR-322 was digested with 200 µl of the reaction mixture by reacting with 37.2 units of PstI at 37 ° C for 2 hours and then further reacted with 500 µl of the reaction mixture with 132 units of EcoRI for 2 hours. Thereafter, agarose gel electrophoresis 0.8% preparation, DNA fragment containing ori and Tc r (3.6 Kb
p) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 11 μl (˜1 μg / μl).

そして、pSVO10/neorのneorを含むEcoRI/PstI断片のD
NA溶液1μl(〜1μg)と、pBR−322のori及びTcr
含むEcoRI/PstI断片のDNA溶液1μl(〜1μg)と
を、反応混液20μlで6ユニツトのT4−DNAリガーゼと1
2℃で17.5時間反応させて連結した。その後、フエノー
ル抽出を行ない、DNAをエタノール沈澱として得、沈澱
を0.1M Tris−HCl(pH7.5)溶液20μlに溶解させた。
Then, D of EcoRI / PstI fragment containing the neo r of PSVO10 / neo r
NA solution and 1μl (~1μg), and pBR-322 of ori and DNA solution 1 [mu] l of EcoRI / PstI fragment containing the Tc r (~1μg), and T4-DNA ligase reaction mixture 20μl 6 Yunitsuto 1
The reaction was carried out at 2 ° C for 17.5 hours for ligation. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、Kmr(neor)かつTcr,Aps
クローンを得た。次いでこれらのクローンをもつプラス
ミドDNAの特性を調べて、pBR−322にneor断片を挿入さ
せたプラスミド:pBR−322/neor(第8図)を持つ大腸菌
を得た。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Km r (neo r ) and Tc r , Ap s were obtained.
I got a clone. Then, the properties of the plasmid DNA having these clones were examined to obtain Escherichia coli having the plasmid: pBR-322 / neo r (Fig. 8) in which the neo r fragment was inserted into pBR-322.

この大腸菌を、TYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製してpBR−322/neor
プラスミドDNAを調製した。
The E. coli, in TYG-P medium 1, then grown, and plasmid DNA was prepared in pBR-322 / neo r a ccc-DNA from the cells was separated and purified.

(h)pBR−322/neorΔ(EcoRI/BalI)の作成及び調製 pBR−322/neor 10μgを反応混液100μlで40ユニツ
トのBalIと37℃で2時間反応させて消化したのち、さら
に反応混液250μlで120ユニツトのEcoRIと37℃で2時
間反応させて消化した。そして、フエノール抽出で除蛋
白後、DNAをエタノール沈澱として得、沈澱を10t/0.1E
7μl(〜1μg/μl)に溶解させた。
(H) Preparation and preparation of pBR-322 / neo r Δ (EcoRI / BalI) 10 µg of pBR-322 / neo r was reacted with 40 units of BalI in 100 µl of the reaction mixture at 37 ° C for 2 hours for digestion, followed by further reaction. 250 μl of the mixed solution was reacted with 120 units of EcoRI at 37 ° C. for 2 hours for digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was extracted with 10t / 0.1E.
It was dissolved in 7 μl (˜1 μg / μl).

次に、このBalIとEcoRIで消化したDNA溶液1μl(〜
1μg)を、反応混液25μlで、2ユニツトのKlenow酵
素と22℃で30分間反応させて、cohesive endをblunt en
dに変えた。そして、反応液を65℃で10分間熱処理してK
lenow酵素を失活させた。
Next, 1 μl of the DNA solution digested with this BalI and EcoRI (~
1 μg) with 25 μl of the reaction mixture and reacted with 2 units of Klenow enzyme at 22 ° C for 30 minutes to blunt en the cohesive end.
changed to d. Then, heat the reaction solution at 65 ° C for 10 minutes to obtain K
deactivated the lenow enzyme.

次に、このDNA溶液10μl(〜0.4μg)を反応混液50
μlで、15ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて閉環化したのち(この場合、EcoRIサイト
が再構成される)、フエノール抽出を抽出を行ない、DN
Aをエタノール沈澱として得、沈澱を0.1M Tris−HCl(p
H7.5)溶液20μlに溶解させた。
Next, add 10 μl (~ 0.4 μg) of this DNA solution to the reaction mixture 50
After cyclization with 15 μl of 15-unit T4-DNA ligase at 12 ° C for 17.5 hours (in this case, EcoRI site is reconstituted), phenol extraction was performed and DN extraction was performed.
A was obtained as an ethanol precipitate, and the precipitate was mixed with 0.1 M Tris-HCl (p
H7.5) solution was dissolved in 20 μl.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、neor(Kmr)かつTcs,Ap
sクローンを得た。次いでこれらのクローンのもつプラ
スミドDNAの特性を調べて、pBR−322/neorのEcoRIサイ
トとBalIサイトとの間のDNA断片(1.42Kbp)を欠いたプ
ラスミド:pBR−322/neorΔ(EcoRI/BalI)(第8図)を
持つ大腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, neo r (Km r ) and Tc s , Ap were obtained.
s clone was obtained. Then examine the characteristics of plasmid DNA possessed by these clones, pBR-322 / neo r of EcoRI sites and DNA fragment between the BalI site (1.42Kbp) the lack plasmid: pBR-322 / neo r Δ (EcoRI / BalI) (Fig. 8) was obtained.

この大腸菌を、TYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製して、pBR−322/neor
Δ(EcoRI/BalI)のプラスミドDNAを調製した。
The E. coli, in TYG-P medium 1, then grown, and separated and purified ccc-DNA from the cells, pBR-322 / neo r
A Δ (EcoRI / BalI) plasmid DNA was prepared.

(i)pDcos Apr/oriの作成及び調製 pDcos Apr/ori/dhfr(BamHI)20μgを反応混液200μ
lで、4.1ユニツトのPstIと37℃で30分間反応させて限
定消化した。次いでフエノール抽出で除蛋白後、DNAを
エタノール沈澱として得た。
(I) pDcos Ap r / ori creation and preparation pDcos Ap r / ori / dhfr ( BamHI) 20μg reaction mixture 200μ
The reaction was carried out for 30 minutes at 37.degree. C. with 4.1 units of PstI for limited digestion. Then, after deproteinizing by phenol extraction, DNA was obtained as an ethanol precipitate.

このDNA沈澱を、反応混液200μlで49ユニツトのPvuI
Iと37℃で2時間反応させて消化した。
This DNA precipitate was mixed with 200 μl of the reaction mixture to obtain 49 units of PvuI.
It was digested by reacting with I at 37 ° C. for 2 hours.

その後、0.8%調製用アガロースゲル電気泳動にかけ
て、2個のcos及びori,Aprを含むDNA断片(2.3Kbp)を
分離精製して、DNAをエタノール沈澱として得、沈澱を1
0t/0.1E 8μl(〜1μg/μl)に溶解させた。
Then, it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify the DNA fragment (2.3 Kbp) containing the two cos, ori, and Ap r, and the DNA was obtained as an ethanol precipitate.
It was dissolved in 8 μl of 0t / 0.1E (˜1 μg / μl).

一方、pBR−322/neorΔ(EcoRI/BalI)20μgを反応
混液500μlで、56ユニツトのPvuII及び47ユニツトのPs
tIと37℃で2時間反応させて完全に消化したのち、0.8
%調製用アガロースゲル電気泳動にかけて、neorを含む
DNA断片(1.9Kbp)を分離精製して、DNAをエタノール沈
澱として得、沈澱を10t/0.1E 8μl(〜1μg/μl)に
溶解させた。
On the other hand, the reaction mixture 500μl of pBR-322 / neo r Δ ( EcoRI / BalI) 20μg, 56 Yunitsuto PvuII and 47 Yunitsuto of Ps
After reacting with tI at 37 ℃ for 2 hours to completely digest, 0.8
% Preparative agarose gel electrophoresis, including neo r
The DNA fragment (1.9 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 8 μl of 10 t / 0.1E (˜1 μg / μl).

そして、pDcos Apr/ori/dhfr(BamHI)のcos及びori,
Aprを含むPvuII/PstI断片のDNA溶液1μl(〜1μg)
と、pBR−322/neorΔ(EcoRI/BalI)のneorを含むPvuII
/PstI断片のDNA溶液1μl(〜1μg)とを、反応混液
20μlで6ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて連結した。その後、フエノール抽出を行な
いDNAをエタノール沈澱として得、沈澱を0.1M Tris−HC
l(pH7.5)溶液20μlに溶解させた。
And pDcos Ap r / ori / dhfr (BamHI) cos and ori,
1 μl (~ 1 μg) DNA solution of PvuII / PstI fragment containing Ap r
And PvuII containing neo r of pBR-322 / neo r Δ (EcoRI / BalI)
/ PstI fragment DNA solution 1 μl (~ 1 μg) and reaction mixture
Ligation was performed by reacting with 20 μl of 6-unit T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was mixed with 0.1 M Tris-HC.
It was dissolved in 20 μl of 1 (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、Aprかつneor(Kmr)クロー
ンを得た。次でこれらのクローンをもつプラスミドDNA
の特性を調べて、2個のcos及びori,Apr,neorを有する
プラスミド:pDcos Apr/ori(第1,8図)を持つ大腸菌を
得た。なお、本菌株は、工業技術院微生物工業技術研究
所に「微工研菌第7553号(FERMP−7553)」として寄託
されている。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and neo r (Km r ) clones were obtained. Next, plasmid DNA containing these clones
Was examined to obtain Escherichia coli harboring a plasmid having two cos and ori, Ap r and neo r : pDcos Ap r / ori (Fig. 1, 8). This strain has been deposited at the Institute of Microbial Science and Technology of the Agency of Industrial Science and Technology as "Microindustrial Research Institute No. 7553 (FERMP-7553)".

この大腸菌をTYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Apr/ori
のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Ap r / ori
Was prepared.

実施例4 pDcos Apr/ori/gpt/TKの作成及び調製(第9
図) (a)pSV2−gptΔ(HindIII/BglII)の作成及び調製 pSV2−gpt〔Richard,Mulligan & Berg,Mol.Cell.Bio
l.,1,449,(1981)〕10μgを、反応混液100μlで、46
ユニツトのHindIII及び46ユニツトのBglIIと37℃で2時
間反応させて消化した。そして、フエノール抽出で除蛋
白後、DNAをエタノール沈澱として得、沈澱を10t/0.1E
7μl(〜1μg/μl)に溶解させた。
Example 4 Preparation and preparation of pDcos Ap r / ori / gpt / TK (No. 9)
(A) Preparation and preparation of pSV2-gptΔ (HindIII / BglII) pSV2-gpt [Richard, Mulligan & Berg, Mol.Cell.Bio
l., 1 , 449, (1981)] 10 μg in 100 μl of the reaction mixture,
It was digested by reacting with HindIII of unit and BglII of 46 unit at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was extracted with 10t / 0.1E.
It was dissolved in 7 μl (˜1 μg / μl).

次に、このHindIII及びBglIIで消化したDNA溶液1μ
l(〜1μg)を、反応混液25μlで2ユニツトのKlen
ow酵素と22℃で30分間反応させて、cohesive endをblun
t endに変えた。そして、反応液を65℃で10分間熱処理
してKlenow酵素を失活させた。
Next, 1 μl of the DNA solution digested with this HindIII and BglII
1 unit (up to 1 μg) was added to 2 units of Klen in 25 μl of the reaction mixture.
ow the enzyme with ow enzyme for 30 minutes at 22 ℃ and blun the cohesive end.
changed to t end. Then, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate the Klenow enzyme.

次に、このDNA溶液10μl(〜4.9μg)を反応混液50
μlで、15ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて閉環化したのち、フエノール抽出を行な
い、DNAをエタノール沈澱として得、沈澱を0.1M Tris−
HCl(pH7.5)溶液20μlに溶解させた。
Next, add 10 μl (~ 4.9 μg) of this DNA solution to the reaction mixture 50
After cyclization with 15 μl of T4-DNA ligase (15 units) at 12 ° C. for 17.5 hours, folloWed by phenol extraction, the DNA Was obtained as an ethanol precipitate.
It was dissolved in 20 μl of HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Aprクローンを得た。次
いで、これらのクローンのもつプラスミドDNAの特性を
調べて、pSV2−gptのHindIIIサイトとBglIIサイトとの
間のDNA断片(0.12Kbp)を欠いたプラスミド:pSV2−gpt
Δ(HindIII/BglII)(第9図)を持つ大腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and a plasmid lacking the DNA fragment (0.12 Kbp) between the HindIII site and the BglII site of pSV2-gpt: pSV2-gpt
Escherichia coli having Δ (HindIII / BglII) (FIG. 9) was obtained.

この大腸菌を、TYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製してpSV2−gptΔ(Hin
dIII/BglII)のプラスミドDNAを調製した。
This E. coli was grown in TYG-P medium 1, and then ccc-DNA was separated and purified from the cells to obtain pSV2-gptΔ (Hin
dIII / BglII) plasmid DNA was prepared.

(b)pSV2−gptΔ(HindIII/BglII)/BamHIの作成及び
調製 pSV2−gptΔ(HindIII/BglII)10μgを反応混液100
μlで18.8ユニツトのPvuIIと37℃で2時間反応させて
消化した。そして、フエノール抽出で除蛋白後、DNAを
エタノール沈澱として得、沈澱を10t/0.1E 7μl(〜1
μg/μl)に溶解させた。
(B) Preparation and preparation of pSV2-gptΔ (HindIII / BglII) / BamHI pSV2-gptΔ (HindIII / BglII) 10 μg was added to the reaction mixture 100
This was digested with 1 μl of PvuII (18.8 unit) at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was 10 t / 0.1E 7 μl (~ 1
μg / μl).

次に、このDNA溶液0.4μl(〜0.4μg)と、BamHIリ
ンカー〔d(pC−A−G−A−T−C−C−G)〕2μ
gとを、反応混液20μlで6ユニツトのT4−DNAリガー
ゼと22℃で6時間反応させて連結した。その後、フエノ
ール抽出を行ない、DNAをエタノール沈澱として得た。
Next, 0.4 μl (-0.4 μg) of this DNA solution and 2 μm of BamHI linker [d (pC-A-G-A-T-C-C-G)]
20 g of the reaction mixture was reacted with 6 units of T4-DNA ligase at 22 ° C for 6 hours for ligation. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.

このDNA沈澱を、反応混液600μlで1000ユニツトのBa
mHIと37℃で4時間反応させて消化したのち、0.8%調製
用アガロースゲル電気泳動にかけて、5.1Kbpの長さのDN
A断片を分離精製して、DNAをエタノール沈澱とした。
This DNA precipitate was mixed with 600 μl of the reaction mixture to obtain 1000 units of Ba.
After digestion with mHI for 4 hours at 37 ℃, it was electrophoresed on 0.8% preparative agarose gel to give a DN of 5.1 Kbp in length.
The A fragment was separated and purified, and the DNA was subjected to ethanol precipitation.

このDNA沈澱を反応混液20μlで6ユニツトのT4−DNA
リガーゼと12℃17.5時間反応させて閉環化したのち、フ
エノール抽出を行ない、DNAをエタノール沈澱として
得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μlに溶解
させた。
This DNA precipitate was mixed with 20 µl of the reaction mixture to prepare 6 units of T4-DNA.
After cyclization by reacting with ligase at 12 ° C. for 17.5 hours, phenol extraction was carried out to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Aprクローンを得た。次
で、これらのクローンをもつプラスミドDNAの特性を調
べて、pSV2−gptΔ(HindIII/BglII)のPvuIIサイトにB
amHIリンカーを挿入させたプラスミド:pSV2−gptΔ(Hi
ndIII/BglII)/BamHI(第9図)を持つ大腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Next, the characteristics of the plasmid DNA containing these clones were examined, and a Bv site at the PvuII site of pSV2-gptΔ (HindIII / BglII) was examined.
Plasmid with amHI linker inserted: pSV2-gptΔ (Hi
E. coli having ndIII / BglII) / BamHI (Fig. 9) was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpSV2−gptΔ(Hin
dIII/BglII)/BamHIのプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, pccV2-gptΔ (Hin
A plasmid DNA of dIII / BglII) / BamHI was prepared.

(c)pDcos Apr/ori/gpt(2 BamHI)の作成及び調製 pSV2−gptΔ(HindIII/BglII)BamHI 20μgを反応混
液200μlで、226ユニツトのBamHIと37℃で2時間反応
させて消化したのち、0.8%調製用アガロースゲル電気
泳動にかけて、gptを含むDNA断片(2.2Kbp)を分離精製
して、DNAをエタノール沈澱として得、沈澱を10t/0.1E
8.5μl(〜1μg/μl)に溶解させた。
(C) Preparation and preparation of pDcos Ap r / ori / gpt (2 BamHI) 20 μg of pSV2-gptΔ (HindIII / BglII) BamHI was reacted with 200 μl of the reaction mixture for 2 hours at 37 ° C. with BamHI of 226 units, followed by digestion. , 0.8% preparative agarose gel electrophoresis to separate and purify the DNA fragment containing gpt (2.2 Kbp) to obtain DNA as an ethanol precipitate. The precipitate was 10 t / 0.1E.
It was dissolved in 8.5 μl (˜1 μg / μl).

一方、pDcosApr/ori/dhfr(BamHI)10μgを反応混液
100μlで74ユニツトのBamHIと37℃で2時間反応させて
消化した。そして、フエノール抽出で除蛋白後、DNAを
エタノール沈澱として得、沈澱を10t/0.1 E7μl(〜1
μg/μl)に溶解させた。
On the other hand, the pDcosAp r / ori / dhfr (BamHI ) 10μg reaction mixture
It was digested by reacting with 100 μl of 74 unit BamHI at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1 E7 μl (~ 1
μg / μl).

そして、pSV2−gptΔ(HindIII/BglII)/BamHIのgpt
を含むBamHI断片のDNA溶液1μl(〜1μg)と、pDco
sApr/ori/dhfr(BamHI)をBamHIで消化したDNA溶液1μ
l(〜1μg)とを、反応混液20μlで6ユニツトのT4
−DNAリガーゼと12℃で17.5時間反応させて連結した。
その後、フエノール抽出を抽出を行ない、DNAをエタノ
ール沈澱として得、沈澱を0.1M Tris−HCl(pH7.5)溶
液20μlに溶解させた。
Then, pSV2-gptΔ (HindIII / BglII) / BamHI gpt
Containing 1 μl (~ 1 μg) of BamHI fragment DNA solution containing pDco
sAp r / ori / dhfr DNA solution 1μ the (BamHI) was digested with BamHI
1 unit (~ 1 μg) with 20 μl of reaction mixture and 6 units of T4
-Ligation was carried out by reacting with DNA ligase at 12 ° C for 17.5 hours.
Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、Aprクローンを得た。次い
で、これらのクローンのもつプラスミドDNAの特性を調
べて、pDcos Apr/ori/dhfrのBamHIサイトにgptを挿入さ
せたプラスミド:pDcos Apr/ori/gpt(2BamHI)(第9
図)を持つ大腸菌を得た。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r clone was obtained. Next, the characteristics of the plasmid DNA possessed by these clones were examined, and a plasmid in which gpt was inserted into the BamHI site of pDcos Ap r / ori / dhfr: pDcos Ap r / ori / gpt (2BamHI) (9th
E. coli having (Fig.) Was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製してpDcos Apr/ori/gp
t(2BamHI)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Ap r / ori / gp.
Plasmid DNA of t (2BamHI) was prepared.

(d)pDcos Apr/ori/gptの作成及び調製 pDcos Apr/ori/gpt(2BamHI)10μgを、反応混液100
μlで9.1ユニツトのBamHIと37℃で30分間反応させて限
定消化した。そして、フエノール抽出で除蛋白後、DNA
をエタノール沈澱として得、沈澱を10t/0.1E 7μl(〜
1μg/μl)に溶解させた。
(D) the pDcos Ap r / ori / gpt creation and preparation pDcos Ap r / ori / gpt ( 2BamHI) 10μg, the reaction mixture 100
It was reacted with 9.1 unit of BamHI in μl for 30 minutes at 37 ° C. for limited digestion. After deproteinization with phenol extraction, DNA
Was obtained as an ethanol precipitate, and the precipitate was mixed with 10 t / 0.1E 7 μl (~
1 μg / μl).

次に、このBamHIで限定消化したDNA溶液1μl(〜1
μg)を、反応混液25μlで2ユニツトのKlenow酵素と
22℃で30分間反応させて、cohesive endをblunt endに
変えたのち、0.8%調製用アガロースゲル電気泳動にか
けて、6.3Kbpの長さのDNA断片を分離精製して、DNAをエ
タノール沈澱として得た。
Next, 1 μl of DNA solution (~ 1
μg) with 2 units of Klenow enzyme in 25 μl of reaction mixture
After reacting at 22 ° C for 30 minutes, changing cohesive end to blunt end, 0.8% preparative agarose gel electrophoresis was performed, and a 6.3 Kbp-long DNA fragment was separated and purified to obtain DNA as an ethanol precipitate. .

このDNA沈澱を反応混液20μlで6ユニツトのT4−DNA
リガーゼと12℃で17.5時間反応させて閉環化したのち、
フエノール抽出を抽出を行ない、DNAをエタノール沈澱
として得、沈澱を0.1M Tris−HCl(pH7.5)溶液20μl
に溶解させた。
This DNA precipitate was mixed with 20 µl of the reaction mixture to prepare 6 units of T4-DNA.
After cyclization by reacting with ligase at 12 ° C for 17.5 hours,
Extraction with phenol was performed to obtain DNA as an ethanol precipitate. The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution (20 μl).
Dissolved in.

そして、このDNA溶液10μlで大腸菌(HB101)をトラ
ンスホーメーシヨンしたのち、Aprクローンを得た。次
でこれらのクローンをもつプラスミドDNAの特性を調べ
て、pDcos Apr/ori/gpt(2BamHI)のcosとgptとの間のB
amHIサイトを欠いたプラスミド:pDcos Apr/ori/gpt(第
9図)を持つ大腸菌を得た。
After transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. We next characterized the plasmid DNAs carrying these clones to find the B between the cos and gpt of pDcos Ap r / ori / gpt (2BamHI).
Escherichia coli having a plasmid lacking amHI site: pDcos Ap r / ori / gpt (Fig. 9) was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Apr/ori/
gptのプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Ap r / ori /
A gpt plasmid DNA was prepared.

(e)pTK−4/BamHIの作成及び調製 pTK−4〔Ishiura,M.,etal.Mol.Cell Biol,2,607(19
82)〕10μgを反応混液100μlで、3.0ユニツトのPvuI
Iと37℃で30分間反応させて限定消化したのち、0.8%調
製用アガロースゲル電気泳動にかけて、6.43Kbpの長さ
のDNA断片を分離精製して、DNAをエタノール沈澱として
得、沈澱を10t/0.1E 3μl(〜1μg/μl)に溶解させ
た。
(E) Preparation and preparation of pTK-4 / BamHI pTK-4 [Ishiura, M., et al. Mol. Cell Biol, 2 , 607 (19
82)] 10 μg was added to 100 μl of the reaction mixture to obtain 3.0 units of PvuI.
After reacting with I for 30 minutes at 37 ° C and limited digestion, it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify a 6.43 Kbp long DNA fragment to obtain DNA as an ethanol precipitate. It was dissolved in 3 μl of 0.1E (˜1 μg / μl).

次に、このDNA溶液0.4μl(〜0.4μg)と、BamHIリ
ンカー〔d(pC−G−G−A−T−C−C−G)〕2μ
gとを、反応混液20μlで6ユニツトのT4−DNAリガー
ゼと22℃で6時間反応させて連結した。
Next, 0.4 μl (-0.4 μg) of this DNA solution and 2 μm of BamHI linker [d (pC-G-G-A-T-C-C-G)]
20 g of the reaction mixture was reacted with 6 units of T4-DNA ligase at 22 ° C for 6 hours for ligation.

そして、この反応液10μlを、反応混液50μlで15ユ
ニツトのT4−DNAリガーゼと12℃で17.5時間反応させて
閉環化した。その後フエノール抽出を行ない、DNAをエ
タノール沈澱として得、沈澱を0.1M Tris−HCl(pH7.
5)溶液20μlに溶解させた。
Then, 10 μl of this reaction mixture was reacted with 15 units of T4-DNA ligase in 50 μl of the reaction mixture at 12 ° C. for 17.5 hours for cyclization. After that, phenol extraction was performed to obtain DNA as an ethanol precipitate, which was precipitated with 0.1 M Tris-HCl (pH 7.
5) The solution was dissolved in 20 μl.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、AprかつTcrクローンを得
た。そして、これらのクローンのもつプラスミドDNAの
特性を調べて、pTK−4のoriとTKとの間のPvuIIサイト
にBamHIリンカーを挿入させたプラスミド:pTK−4/BamHI
(第9図)を持つ大腸菌を得た。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc r clones were obtained. Then, the characteristics of the plasmid DNA of these clones were examined, and a plasmid having a BamHI linker inserted at the PvuII site between ori and TK of pTK-4: pTK-4 / BamHI
E. coli having (Fig. 9) was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製して、pTK−4/BamHIの
プラスミドDNAを調製した。
This Escherichia coli was grown in TYG-P medium 1, and ccc-DNA was separated and purified from the cells to prepare pTK-4 / BamHI plasmid DNA.

(f)pTK−4/BamHI/BamHIの作成及び調製 pTK−4/BamHI 10μgを反応混液100μlで9ユニツト
のBamHIと37℃で30分間反応させて限定消化したのち、
フエノール抽出を行ない、DNAをエタノール沈澱として
得た。
(F) Preparation and preparation of pTK-4 / BamHI / BamHI 10 μg of pTK-4 / BamHI was reacted with 9 units of BamHI in 100 μl of the reaction mixture at 37 ° C. for 30 minutes for limited digestion,
A phenol extraction was performed to obtain DNA as an ethanol precipitate.

このエタノール沈澱を反応混液100μlで15ユニツト
のPvuIIと37℃で2時間反応させて完全に消化したの
ち、フエノール抽出を行ない、DNAをエタノール沈澱と
して得、沈澱を10t/0.1E 3μl(〜1μg/μl)に溶解
させた。
This ethanol precipitate was completely digested by reacting 100 μl of the reaction mixture with 15 units of PvuII at 37 ° C. for 2 hours, followed by phenol extraction to obtain DNA as ethanol precipitate, and the precipitate was 10 t / 0.1E 3 μl (~ 1 μg / ~ 1 μg / μl).

次に、このBamHIで限定消化し、さらにPvuIIで消化し
たDNA溶液1μl(〜1μg)を、反応混液25μlで2
ユニツトのKlenow酵素と22℃で30分間反応させて、cohe
sive endをblunt endに変えたのち、0.8%調製用アガロ
ースゲル電気泳動にかけて、ori及びApr,TKを含むDNA断
片(4.67Kbp)を分離精製して、DNAをエタノール沈澱と
して得た。
Next, 1 μl (~ 1 μg) of the DNA solution digested with this BamHI and further digested with PvuII was added to 25 μl of the reaction mixture to prepare 2
Incubate with Klenow enzyme from unit for 30 minutes at 22 ℃ to remove cohe
After changing the sive end to blunt end, it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify the DNA fragment (4.67 Kbp) containing ori and Ap r , TK to obtain the DNA as ethanol precipitation.

このDNA沈澱を反応混液20μlで6ユニツトのT4−DNA
リガーゼと12℃で17.5時間反応させて閉環化したのち
(この場合、BamHIサイトが再構成される)、フエノー
ル抽出を行ない、DNAをエタノール沈澱として得、沈澱
を0.1M Tris−HCl(pH7.5)溶液20μlに溶解させた。
This DNA precipitate was mixed with 20 µl of the reaction mixture to prepare 6 units of T4-DNA.
After cyclization by reacting with ligase at 12 ° C for 17.5 hours (in this case, BamHI site is reconstituted), phenol extraction was performed to obtain DNA as ethanol precipitate, and the precipitate was extracted with 0.1M Tris-HCl (pH7.5 ) Dissolved in 20 μl of solution.

そして、このDNA溶液10μlで、大腸菌(HB101)をト
ランスホーメーシヨンしたのち、AprかつTcsクローンを
得た。次いでこれらのクローンのもつプラスミドDNAの
特性を調べて、pTK−4/BamHIのPvuIIサイトとBamHIサイ
ト(Tcr上)の間のDNA断片(1.76Kbp)を欠いたプラス
ミド:pTK−4/BamHI/BamHI(第9図)を持つ大腸菌を得
た。
Then, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and Tc s clones were obtained. Then examine the characteristics of plasmid DNA possessed by these clones, pTK-4 / BamHI of PvuII and BamHI sites (Tc r on) DNA fragment (1.76Kbp) the lack plasmid between: pTK-4 / BamHI / E. coli with BamHI (Fig. 9) was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製して、pTK−4/BamHI/B
amHIのプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells and pTK-4 / BamHI / B was isolated.
AmHI plasmid DNA was prepared.

(g)pDcos Apr/ori/gpt/TK(2BamHI)の作成及び調製 pTK−4/BamHI/BamHI 20μgを反応混液200μlで247
ユニツトのBamHIと37℃で2時間反応させて消化したの
ち、1.0%調製用アガロースゲル電気泳動にかけて、TK
を含むDNA断片(2Kbp)を分離精製して、DNAをエタノー
ル沈澱として得、沈澱を10t/0.1E 6μl(〜1μg/μ
l)に溶解させた。
(G) Preparation and preparation of pDcos Ap r / ori / gpt / TK (2BamHI) pTK-4 / BamHI / BamHI 20 μg was added to the reaction mixture 200 μl in 247
After reacting with unit's BamHI at 37 ℃ for 2 hours and digesting, it was subjected to 1.0% preparative agarose gel electrophoresis and TK
A DNA fragment (2 Kbp) containing DNA was isolated and purified to obtain DNA as an ethanol precipitate. The precipitate was mixed with 10 t / 0.1E 6 μl (∼1 μg / μl).
l).

一方、pDcos Apr/ori/gpt 10μgを反応混液100μl
で、91ユニツトのBamHIと37℃で2時間反応させて消化
した。そして、フエノール抽出で除蛋白後、DNAをエタ
ノール沈澱として得沈澱を10t/0.1E 7μl(〜1μg/μ
l)に溶解させた。
On the other hand, pDcos Ap r / ori / gpt 10 μg was added to the reaction mixture 100 μl
Then, it was digested by reacting with 91 unit BamHI at 37 ° C for 2 hours. After deproteinization by phenol extraction, DNA was obtained as ethanol precipitate, and the precipitate was 10t / 0.1E 7 μl (~ 1 μg / μ
l).

そして、pTK−4/BamHI/BamHIのTKを含むBamHI断片のD
NA溶液1μl(〜1μg)と、pDcos Apr/ori/gptをBam
HIで消化したDNA溶液1μl(〜1μg)とを、反応混
液20μlで6ユニツトのT4−DNAリガーゼと12℃で17.5
時間反応させて連結した。その後フエノール抽出を行な
い、DNAをエタノール沈澱として得、沈澱を0.1M Tris−
HCl(pH7.5)溶液20μlに溶解させた。
Then, D of BamHI fragment containing TK of pTK-4 / BamHI / BamHI
Bam the NA solution 1 μl (~ 1 μg) and pDcos Ap r / ori / gpt
1 μl (~ 1 μg) of the DNA solution digested with HI was added to 20 μl of the reaction mixture and 6 units of T4-DNA ligase and 17.5 at 12 ° C.
After reacting for a period of time, they were connected. After that, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was mixed with 0.1 M Tris-
It was dissolved in 20 μl of HCl (pH 7.5) solution.

次に、このDNA溶液10μlで大腸菌(HB101)をトラン
スホーメーシヨンしたのち、Aprクローンを得た。次い
で、これらのクローンのもつプラスミドDNAの特性を調
べて、pDcos Apr/ori/gptのBamHIサイトにTKを挿入させ
たプラスミド:pDcos Apr/ori/gpt/TK(2BamHI)(第9
図)を持つ大腸菌を得た。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r clone was obtained. Then, by examining the characteristics of plasmid DNA possessed by these clones, pDcos Ap r / ori / gpt plasmid was inserted the TK into the BamHI site: pDcos Ap r / ori / gpt / TK (2BamHI) ( 9
E. coli having (Fig.) Was obtained.

この大腸菌を、TYG−P培地1中で増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Apr/ori/
gpt/TK(2BamHI)のプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells to obtain pDcos Ap r / ori /
A plasmid DNA of gpt / TK (2BamHI) was prepared.

(h)pDcos Apr/ori/gpt/TKの作成及び調製 pDcos Apr/ori/gpt/TK(2BamHI)10μgを反応混液10
0μlで、6.9ユニツトのBamHIと37℃で30分間反応させ
て限定消化した。そしてフエノール抽出で除蛋白後、DN
Aをエタノール沈澱として得、沈澱を10t/0.1E7μl(〜
1μg/μl)に溶解させた。
(H) pDcos Ap r / ori / gpt / TK creation and preparation pDcos Ap r / ori / gpt / TK (2BamHI) 10μg reaction mixture 10
This was digested with 0 μl of BamHI (6.9 unit) at 37 ° C. for 30 minutes for limited digestion. After deproteinization with phenol extraction, DN
A was obtained as an ethanol precipitate, and the precipitate was mixed with 10 t / 0.1E 7 μl (~
1 μg / μl).

次に、このBamHIで限定消化したDNA溶液1μl(〜1
μg)を、反応混液25μlで2ユニツトのKlenow酵素と
22℃で30分間反応させて、cohesive endをblunt endに
変えたのち、0.8%調製用アガロースゲル電気泳動にか
けて、8.3Kbpの長さのDNA断片を分離精製して、DNAをエ
タノール沈澱として得た。
Next, 1 μl of DNA solution (~ 1
μg) with 2 units of Klenow enzyme in 25 μl of reaction mixture
After reacting at 22 ° C for 30 minutes and changing cohesive end to blunt end, 0.8% preparative agarose gel electrophoresis was performed to separate and purify a DNA fragment with a length of 8.3 Kbp to obtain DNA as an ethanol precipitate. .

そして、このDNA沈澱を反応混液20μlで6ユニツト
のT4−DNAリガーゼと12℃で17.5時間反応させて閉環化
したのち、フエノール抽出を行ない、DNAをエタノール
沈澱として得、沈澱を0.1M Tris−HCl(pH7.5)溶液20
μlに溶解させた。
The DNA precipitate was reacted with 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours for cyclization, followed by phenol extraction to obtain the DNA as ethanol precipitate. The precipitate was 0.1M Tris-HCl. (PH 7.5) solution 20
It was dissolved in μl.

このDNA溶液10μlで大腸菌(HB101)をトランスホー
メーシヨンしたのち、Aprクローンを得た。次いで、こ
れらのクローンのもつプラスミドDNAの特性を調べて、p
Dcos Apr/ori/gpt/TK(2BamHI)のTKと Aprとの間のBa
mHIサイトを欠いたプラスミド:pDcosApr/ori/gpt/TK
(第5、9図)を持つ大腸菌を得た。なお、本菌株は、
工業技術院微生物工業技術研究所に「微工研菌第7552号
(FERMP−7552)」として寄託されている。
After transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r clone was obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and p
Ba between TK and Ap r of Dcos Ap r / ori / gpt / TK (2BamHI)
Plasmid lacking mHI site: pDcosAp r / ori / gpt / TK
E. coli having (Figs. 5 and 9) were obtained. In addition, this strain is
It has been deposited at the Institute of Microbial Science and Technology of the Agency of Industrial Science and Technology as "Micro Engineering Research Institute No. 7552 (FERMP-7552)".

この大腸菌を、TYG−P培地1中で、増殖させたの
ち、菌体よりccc−DNAを分離精製して、pDcos Apr/ori/
gpt/TKのプラスミドDNAを調製した。
After this E. coli was grown in TYG-P medium 1, ccc-DNA was separated and purified from the cells, and pDcos Ap r / ori /
A plasmid DNA of gpt / TK was prepared.

実施例5 pDcos Apr/oriによるゲノムDNA(外来DNA)
の遺伝子バンクの製造(第2図参照) (a)高分子量のゲノムDNAの調製 pBR−322の塩基配列を持つ、ヘルペスシンプレツクウ
イルス1型(HSV−1)のチミジンキナーゼ(TK)遺伝
子の組み換え体を移入したマウスL細胞(Ltk-〔HSV−
1TK+〕)は、10%仔牛血清を添加したイーグルMEMで培
養し、confluent monolayers(100mm−プレート9枚、
〜107cells/プレート)とし、PBS(137mM NaCl1,3mMKCl
1,8mM Na2HPO4,1mM KH2PO4)で2度洗つたのち、可溶化
剤(100μg/mlProteinase K 0.5%SDS,150mM NaCl,10mM
EDTA,10mM Tris−HCl(pH7.5))をプレート当り1.0ml
加え、65℃で15〜30分間保温して可溶化した。この可溶
化物は50ml容量の遠沈管に移し、さらに37℃で一晩保温
し、途中、ProtinaseKをさらに100μg/ml添加した。反
応後、等量のトリス緩衝液で飽和したフエノールでおだ
やかに2度抽出し、水層を50mM Tris−HCl(pH8.0)、1
0mM EDTA,10mM NaClからなる透析緩衝液3lに対して4回
透析を行なつた。透析内液は、50μg/mlのDNase−free
RNase Aを加えて37℃で3時間保温してRNAを分解した。
反応後、等量のフエノール:クロロホルム混液で2度お
だやかに抽出し、水層を10mM Tris−HCl(pH8.0),1mM
EDTAからなる水溶液(TE)3lに対して9回透析して、精
製DNA溶液50mlを得た。DNA溶液の260nmと280nmでの吸光
度(OD)は、10倍希釈でそれぞれ0.667,0.363(OD280
OD260=0.544)であり、DNAの濃度は0.667×0.050(μg
/1OD)×10=0.334μg/μlであつた。
Example 5 Genomic DNA (foreign DNA) by pDcos Ap r / ori
(See Fig. 2) (a) Preparation of high molecular weight genomic DNA Recombination of thymidine kinase (TK) gene of herpes simplex virus type 1 (HSV-1) having the nucleotide sequence of pBR-322 mouse L cells (Ltk transfected with body - [HSV-
1TK + ]) was cultured in Eagle MEM supplemented with 10% calf serum, and confluent monolayers (100 mm-9 plates,
~ 10 7 cells / plate, PBS (137mM NaCl1,3mM KCl
After washing twice with 1,8mM Na 2 HPO 4 , 1mM KH 2 PO 4 , solubilizer (100μg / ml Proteinase K 0.5% SDS, 150mM NaCl, 10mM
EDTA, 10mM Tris-HCl (pH7.5)) 1.0ml per plate
In addition, it was solubilized by incubating at 65 ° C for 15 to 30 minutes. The solubilized product was transferred to a centrifuge tube having a volume of 50 ml, further incubated at 37 ° C. overnight, and 100 μg / ml of Protinase K was added during the incubation. After the reaction, gently extract twice with an equal volume of phenol saturated with Tris buffer, and the aqueous layer is washed with 50 mM Tris-HCl (pH 8.0), 1
Dialysis was performed 4 times against 3 liters of dialysis buffer consisting of 0 mM EDTA and 10 mM NaCl. The dialysate is 50 μg / ml DNase-free.
RNase A was added and the mixture was kept warm at 37 ° C for 3 hours to decompose RNA.
After the reaction, gently extract with an equal volume of phenol: chloroform mixture twice, and extract the aqueous layer with 10 mM Tris-HCl (pH 8.0), 1 mM.
It was dialyzed 9 times against 3 l of an aqueous solution (TE) consisting of EDTA to obtain 50 ml of a purified DNA solution. The absorbance (OD) of the DNA solution at 260 nm and 280 nm is 0.667, 0.363 (OD 280 / OD 280 /
OD 260 = 0.544) and the DNA concentration is 0.667 × 0.050 (μg
/1OD)×10=0.334 μg / μl.

(b)35〜45KbpのゲノムDNAの調製 精製したゲノムDNA溶液5.98ml(2mg)を、反応混液2
9.96ml(50mM NaCl,10mM Tris−HCl(pH7.5),10mM MgC
l2,100μg/ml BSA)で15.6ユニツトのSau 3A(New Engl
and Biolabs社製)と37℃で1時間反応させて限定消化
したのち、0.5MEDTA(pH8.0)溶液を1.3ml加え、等量の
トリス緩衝液飽和フエノールで2度おだやかに抽出し
た。そして水層をセカンダリーブタノールで10mlまで濃
縮したのち、3.0M酢酸ナトリウム1.1mlとエタノール20m
lを加え、エタノール沈澱としてゲノムDNAを得、70%エ
タノールで洗つたのち水流ポンプにて乾燥を行ない、エ
タノール沈澱をTE2mlに溶解させた。
(B) Preparation of 35 to 45 Kbp genomic DNA 5.98 ml (2 mg) of the purified genomic DNA solution was added to the reaction mixture 2
9.96 ml (50 mM NaCl, 10 mM Tris-HCl (pH 7.5), 10 mM MgC
l 2 , 100 μg / ml BSA) 15.6 unit Sau 3A (New Engl
and Biolabs) for 1 hour at 37 ° C. for limited digestion, 1.3 ml of 0.5 M EDTA (pH 8.0) solution was added, and the mixture was gently extracted twice with an equal volume of Tris buffer saturated phenol. The aqueous layer was concentrated to 10 ml with secondary butanol, then 1.1 ml of 3.0 M sodium acetate and 20 ml of ethanol were added.
l was added to obtain ethanol-precipitated genomic DNA, which was washed with 70% ethanol and dried with a water-jet pump to dissolve the ethanol-precipitate in 2 ml of TE.

次に、このDNA溶液300μlを5〜25%シヨ糖密度勾配
遠心〔20mM Tris−HCl(pH7.6)、5mM EDTA、ベツクマ
ンSW28、20,000rpm、9時間、20℃〕にかけて30滴ごと
に分画した。各分画20μlを0.4%アガロースゲル電気
泳動にかけて長さを測定し、35〜45Kbpの大きさのDNA分
画を集めたのち、TE3lに対して3回透析を行なつた。そ
して透析内液をフエノール抽出後、水層をセカンダリー
ブタノールで濃縮し、DNAをエタノール沈澱として得、
沈澱をTE1mlに溶解させて、35〜45KbpのゲノムDNA溶液
を得た。DNA溶液のOD260及びOD280は50倍希釈でそれぞ
れ0.216,0.112(OD280/OD260=0.519)であり、DNAの
濃度は0.216×0.050(μg/1OD)×50=0.54μg/μlで
あつた。
Next, 300 μl of this DNA solution was subjected to 5-25% sucrose density gradient centrifugation [20 mM Tris-HCl (pH 7.6), 5 mM EDTA, Beckmann SW28, 20,000 rpm, 9 hours, 20 ° C.] to fractionate every 30 drops. did. 20 μl of each fraction was subjected to 0.4% agarose gel electrophoresis to measure the length, DNA fractions having a size of 35 to 45 Kbp were collected, and then dialyzed against TE3l three times. Then, the dialysate was extracted with phenol and the aqueous layer was concentrated with secondary butanol to obtain DNA as an ethanol precipitate,
The precipitate was dissolved in 1 ml of TE to obtain a 35-45 Kbp genomic DNA solution. The OD 260 and OD 280 of the DNA solution were 0.216 and 0.112 (OD 280 / OD 260 = 0.519), respectively, at a 50-fold dilution, and the DNA concentration was 0.216 × 0.050 (μg / 1OD) × 50 = 0.54 μg / μl. It was

(c)コスミドベクターDNAの調製 pDcos Apr/ori 40μgを、反応混液800μlで152ユニ
ツトのPvuIIと37℃で2時間反応させて消化した。その
後、フエノール抽出を行ない、DNAをエタノール沈澱と
して得、沈澱を10t/0.1E 100μlに溶解させた。
(C) Preparation of cosmid vector DNA 40 μg of pDcos Ap r / ori was digested with 152 μl of PvuII in a reaction mixture of 800 μl at 37 ° C. for 2 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 100 μl of 10 t / 0.1E.

このPvuIIで消化したDNA溶液95μlを、反応混液500
μl(50mM Tris−HCl(pH9.0),1mM MgCl2,0.1mM ZnCl
2,1mMスペルジミン)で、6ユニツトのホスフアターゼ
(Calf intestinal alkaline phosphatase,Boehringer,
Mannheim社製)と、37℃で15分間、56℃で15分間反応
後、さらに6ユニツトのホスフアターゼを加え、37℃で
15分間、続いて56℃で15分間反応させて、PvuIIの切断
片を不活化した。その後、H2O400μl,STE(100mM Tris
−HCl(pH8.0)、1M NaCl,10mM EDTA)100μl、10% S
DS 50μlを加え、68℃で15分間保温してホスフアター
ゼを失活させた。そして、フエノール抽出で除蛋白後、
DNAをエタノール沈澱として得、沈澱を10t/0.1E 30μl
に溶解した。
95 μl of this PvuII-digested DNA solution was added to the reaction mixture 500
μl (50 mM Tris-HCl (pH 9.0), 1 mM MgCl 2 , 0.1 mM ZnCl
2, in 1mM Superujimin) of 6 Yunitsuto phosphatase (Calf intestinal alkaline phosphatase, Boehringer,
Mannheim) at 37 ° C for 15 minutes and at 56 ° C for 15 minutes, and then add 6 units of phosphatase.
The fragments of PvuII were inactivated by reacting for 15 minutes and then at 56 ° C for 15 minutes. After that, H 2 O 400 μl, STE (100 mM Tris
-HCl (pH8.0), 1M NaCl, 10 mM EDTA) 100 μl, 10% S
50 μl of DS was added and the phosphatase was inactivated by incubating at 68 ° C. for 15 minutes. And after deproteinizing with phenol extraction,
The DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1E 30 μl
Dissolved in.

次に、このPvuIIで消化し、ホスフアターゼで不活化
したDNA溶液30μlを、反応混液500μlで、152ユニツ
トのBamHIと37℃で2時間反応させて消化した。そし
て、フエノール抽出で除蛋白後、DNAをエタノール沈澱
として得、沈澱を10t/0.1E 30μlに溶解させて、コス
ミドベクターDNA溶液を得た。DNA溶液のOD260及びOD280
は300倍希釈でそれぞれ0.046,0.026(OD280/OD260=0.
565)であり、DNAの濃度は0.046×0.050(μg/1OD)×3
00=0.690μg/μlであつた。
Next, 30 μl of the DNA solution digested with PvuII and inactivated by phosphatase was digested with 500 μl of the reaction mixture by reacting with 152 units of BamHI at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 30 t of 10 t / 0.1E to obtain a cosmid vector DNA solution. OD 260 and OD 280 of DNA solution
Is 0.046, 0.026 (OD 280 / OD 260 = 0.
565), and the DNA concentration is 0.046 × 0.050 (μg / 1OD) × 3
00 = 0.690 μg / μl.

(d)35〜45KbpのゲノムDNAとコスミドベクターDNAと
の連結 (b)で調製した35〜45Kbpのゲノム溶液2.61μl
(1.4μg)と、(c)で調製したコスミドベクターDNA
溶液0.86μl(0.59μg)とを、反応混液10μlで5.9
ユニツトのT4−DNAリガーゼと12℃で17.5時間反応させ
て連結した。反応終了後、反応液は4℃で保存した。
(D) Ligation of 35-45 Kbp genomic DNA with cosmid vector DNA 2.61 μl of 35-45 Kbp genomic solution prepared in (b)
(1.4 μg) and the cosmid vector DNA prepared in (c)
Solution 0.86 μl (0.59 μg) and reaction mixture 10 μl for 5.9
Ligation was performed by reacting with unit T4-DNA ligase at 12 ° C for 17.5 hours. After the reaction was completed, the reaction solution was stored at 4 ° C.

(e)パツケージング抽出液の調製 i)BHB2690から超音波処理して得られる菌体抽出液の
調製 大腸菌BHB2690をNZY培地(1%NZamine,0.5%酵母エ
キス、0.5%NaCl,0.2% MgCl2・6H2O,pH7.5)100mlで
一晩培養した液のOD600を測定後、あらかじめ32℃に保
温しておいたNZY培地500ml(2lフラスコ中)に最初のOD
600が0.025になるように菌を接種し、32℃で振盪培養を
開始した。そして、OD600が0.3になつた時点で(培養開
始から2時間40分後)、45℃で15分間おきプロフアージ
の誘導を行なつた。その後、培養温度を38〜39℃に変
え、さらに3時間激しく振盪培養した(培養液の少量に
クロロホルムを一滴滴下することによつて誘導の検査を
した)。
(E) Preparation of packaged extract i) Preparation of cell extract obtained by ultrasonic treatment from BHB2690 E. coli BHB2690 was added to NZY medium (1% NZamine, 0.5% yeast extract, 0.5% NaCl, 0.2% MgCl 2 ·. 6H 2 O, pH 7.5) After overnight culture in 100 ml, the OD 600 was measured and then the first OD was added to 500 ml of NZY medium (in a 2 l flask) that had been pre-heated to 32 ° C.
Bacteria were inoculated so that 600 became 0.025, and shaking culture was started at 32 ° C. Then, when the OD 600 reached 0.3 (2 hours and 40 minutes after the start of culture), induction of profage was carried out at 45 ° C. for 15 minutes. Then, the culture temperature was changed to 38 to 39 ° C., and the culture was further vigorously shaken for 3 hours (the induction was examined by adding a drop of chloroform to a small amount of the culture solution).

培養終了後、6,000rpmで10分間遠心分離機にかけて集
菌を行ない、菌体を20mM Tris−HCl(pH8.0),1mM EDT
A,5mMβ−メルカプトエタノールからなる緩衝液3.6mlに
懸濁させた。そして、4℃以下で超音波処理(最大出力
で5秒間×20回)を行なつたのち、20,000rpmで10分間
遠心分離機にかけて(4℃)、上澄液〜3mlを得た。
After the culture was completed, the cells were collected by centrifuging at 6,000 rpm for 10 minutes, and the bacterial cells were collected with 20 mM Tris-HCl (pH8.0), 1 mM EDT.
A, 5 mM β-mercaptoethanol was suspended in 3.6 ml of a buffer solution. After sonication (maximum output: 5 seconds × 20 times) at 4 ° C. or lower, centrifugation was performed at 20,000 rpm for 10 minutes (4 ° C.) to obtain ˜3 ml of supernatant.

次に、上澄み液3mlに等量の上記緩衝液とパツケージ
ング緩衝液(6mM Tris−HCl(pH8.0)、50mMスペルジミ
ン、50mMプトレシン、20mM MgCl2,30mM ATP,30mMβ−メ
ルカプトエタノール)0.5mlを加えたのち、15μlづつ
1.5mlのエツペンドルフチユーブに分注し、直ちに液体
窒素中で冷凍し、−70℃で保存した。
Next, 0.5 ml of the above-mentioned buffer and packaging buffer (6 mM Tris-HCl (pH 8.0), 50 mM sperdimine, 50 mM putrescine, 20 mM MgCl 2 , 30 mM ATP, 30 mM β-mercaptoethanol) 0.5 ml in the supernatant 3 ml. After adding, add 15 μl each
It was dispensed into 1.5 ml of Eppendorf tube, immediately frozen in liquid nitrogen, and stored at -70 ° C.

ii)BHB2688から凍結・融解によつて得られる菌体抽出
液の調製 大腸菌2688を、NZY培地100mlで一晩培養した液のOD
600を測定したのち、あらかじめ32℃に保温しておいたN
ZY培地500ml(2lフラスコ中)に最初のOD600が0.025に
なるように菌を接種し、32℃で振盪培養を開始した。そ
して、OD600が0.3になつた時点で(培養開始から2時間
40分後)、45℃で15分間おきプロフアージの誘導を行な
つた。その後、培養温度を38〜39℃に変え、さらに3時
間激しく振盪培養した(培養液の少量にクロロホルムを
一滴、滴下することによつて誘導の検査をした)。
ii) Preparation of cell extract obtained from BHB2688 by freezing and thawing E. coli 2688 was cultured overnight in 100 ml of NZY medium to obtain OD.
After measuring 600 , the N that was previously kept warm at 32 ° C
500 ml of ZY medium (in a 2 l flask) was inoculated with the bacteria so that the initial OD 600 was 0.025, and shake culture was started at 32 ° C. Then, when the OD 600 reached 0.3 (2 hours from the start of culture
After 40 minutes), induction of profage was performed at 45 ° C. for 15 minutes. Then, the culture temperature was changed to 38 to 39 ° C., and the culture was further vigorously shaken for 3 hours (induction test was carried out by adding one drop of chloroform to a small amount of the culture solution).

培養終了後、6,000rpmで10分間遠心分離機にかけて集
菌を行ない、菌体をシヨ糖溶液(10%シヨ糖、50mM Tri
s−HCl(pH8.0)3mlに懸濁させたのち、0.5mlづつエツ
ペンドルフチユーブ6本にとり、この各々のチユーブに
リゾチーム溶液(2mg/ml、0.25M Tris−HCl(pH8.0))
25μlを加え(4℃)、おだやかに混合し、すばやく液
体窒素中にて凍結させた。
After the culture was completed, the cells were collected by centrifuging at 6,000 rpm for 10 minutes, and the cells were taken into a sucrose solution (10% sucrose, 50 mM Tri
After suspending in 3 ml of s-HCl (pH8.0), 0.5 ml each was placed in 6 Etpendorf tubes, and a lysozyme solution (2 mg / ml, 0.25M Tris-HCl (pH8.0)) was added to each tube.
25 μl was added (4 ° C.), mixed gently and immediately frozen in liquid nitrogen.

次に、チユーブを氷上において抽出物を融解させたの
ち、各チユーブにパツケージング緩衝液25μlを加えて
混合した。そして、各抽出物を一緒にして、21,000rpm
で1時間(4℃)遠心分離機にかけて上澄液を得、これ
の10μlづつを1.5mlのエツペンドルフチユーブに分注
し、直ちに液体窒素中で冷凍し、−70℃で保存した。
Next, the tube was thawed on ice to melt the extract, and then 25 μl of packaging buffer was added to each tube and mixed. And each extract together, 21,000rpm
The mixture was centrifuged at 4 ° C. for 1 hour to obtain a supernatant, and 10 μl of the supernatant was dispensed into 1.5 ml of Eppendorf tube, immediately frozen in liquid nitrogen, and stored at −70 ° C.

(f)in vitroパツケージング −70℃に保存しておいたBHB2690とBHB2688の菌体抽出
液を氷上におき、まず先に融解するBHB2688の抽出液をB
HB2690の抽出液に加えておだやかに混合した。ほぼ全部
融解したところで、(d)で調製した組み換え体DNA溶
液2.5μl(0.5μg)を加えてよく混合したのち、室温
で1時間反応させてin vitroパツケージングを行なつ
た。
(F) In vitro packaging The cell extract of BHB2690 and BHB2688 stored at -70 ° C was placed on ice, and the extract of BHB2688 that was thawed first was B.
It was added to the extract of HB2690 and gently mixed. When almost all was melted, 2.5 μl (0.5 μg) of the recombinant DNA solution prepared in (d) was added and mixed well, and then allowed to react at room temperature for 1 hour for in vitro packaging.

反応終了後、SM溶液(0.58%NaCl,0.2%MgSO4・7H
2O,50mM Tris−HCl(pH7.5)0.01%ゲラチン)1mlとク
ロロホルム一滴を加えて混合した。そして、エツペンド
ルフチユーブを机上遠心機に30秒間かけて、上澄液を形
質導入フアージ粒子溶液として得た。
After completion of the reaction, SM solution (0.58% NaCl, 0.2% MgSO 4 · 7H
1 ml of 2 O, 50 mM Tris-HCl (pH 7.5) 0.01% gelatin) and 1 drop of chloroform were added and mixed. Then, the Eppendorf tube was placed on a desk centrifuge for 30 seconds to obtain a supernatant as a transduction-charge particle solution.

(g)形質導入及びプレーテイング 大腸菌HB101のL−ブロス(マルトース0.4%添加)で
一晩培養した液200μlを机上遠心機にかけて集菌を行
ない、その菌体を10mM MgCl2溶液100μlに再懸濁し
た。次に、この菌体懸濁液100μlにSM溶液で10倍希釈
した形質導入フアージ粒子溶液100μlを加え、37℃で1
5分間保温して形質導入を行なつたのち、さらにL−ブ
ロス1.1mlを加え37℃で45分間振盪培養した。そして、
この菌体懸濁液を100μlづつアンピシリン20μg/ml含
有する100mmのL−プレートに塗布し、プレートを37℃
で一晩おいたのち、生ずるコロニーを竹ぐしでついてL
−ブロス(アンピシリン20μg/ml含有)で増殖させた。
また、プレート当りのコロニー数は20〜100個であつ
た。
(G) Transduction and plating 200 μl of an overnight culture of E. coli HB101 in L-broth (0.4% maltose added) was collected on a desk centrifuge and resuspended in 100 μl of 10 mM MgCl 2 solution. did. Next, to 100 μl of this bacterial cell suspension, 100 μl of a solution of transduction fare particles diluted 10-fold with SM solution was added, and the mixture was incubated at 37 ° C. for 1 hour.
After incubating for 5 minutes for transduction, 1.1 ml of L-broth was further added, and the mixture was cultured at 37 ° C for 45 minutes with shaking. And
100 μl of this cell suspension was applied to 100 mm L-plate containing 20 μg / ml of ampicillin, and the plate was kept at 37 ° C.
After overnight, the resulting colonies are attached with bamboo sticks and
-Grown in broth (containing 20 μg / ml ampicillin).
The number of colonies per plate was 20-100.

(h)トランスホーマントの培養及び、それの持つプラ
スミドDNAの調製と特性化 アンピシリン耐性コロニー(トランスホーマント)20
個を、L−ブロス(アンピシリン20μg/ml含有)2mlで
一晩培養したのち、各培養液1.5mlを1.5mlのエツペンド
ルフチユーブにとり、机上遠心機にかけて集菌した。こ
れらの菌体を溶液I(50mMグルコース、25mM Tris−HCl
(pH8.0)、10mM EDTA、4mg/mlリゾチーム)100μlに
再懸濁したのち、室温で5分間おいた。次に、溶液II
(0.2N NaoH,1%SDS)200μlを加えておだやかに混合
し、氷上に5分間おいたのち、溶液III〔5M酢酸カリ(p
H4.8)〕150μlを加えておだやかに混合し、氷上に5
分間おいた。そして、エツペンドルフチユーブを机上遠
心機にかけて上澄液を得、これに2倍容量のエタノール
を加えて、プラスミドDNAをエタノール沈澱として得
た。
(H) Cultivation of transformants and preparation and characterization of their plasmid DNA Ampicillin-resistant colonies (transformants) 20
After culturing the individual pieces in 2 ml of L-broth (containing 20 μg / ml of ampicillin) overnight, 1.5 ml of each culture solution was placed in 1.5 ml of Eppendorf tube and collected on a desk centrifuge. These cells were treated with solution I (50 mM glucose, 25 mM Tris-HCl.
(PH 8.0), 10 mM EDTA, 4 mg / ml lysozyme), and the suspension was resuspended in 100 μl and then left at room temperature for 5 minutes. Next, solution II
(0.2N NaoH, 1% SDS) (200 μl) was added and gently mixed, and the mixture was kept on ice for 5 minutes, and then the solution III [5M potassium acetate (p
H4.8)] Add 150 μl and mix gently, and add 5 on ice.
I left it for a minute. Then, Eppendorf tube was subjected to a desktop centrifuge to obtain a supernatant liquid, and 2 volumes of ethanol was added thereto to obtain a plasmid DNA as an ethanol precipitate.

各トランスホーマントのもつプラスミドDNAを少量の1
0t/0.1Eに溶解させたのち、サイズマーカーDNA(ラムダ
DNA:48Kbp,ラムダDNAをHindIIIで消化したもの:22.3Kb
p,9.5Kbp)と一緒に、0.4%アガロースゲル電気泳動に
かけたところ、アンピシリン耐性コロニー20個のうち、
すべてが22.3Kbp〜48Kbpの大きさのところにプラスミド
DNAの存在が認められた。
A small amount of plasmid DNA in each transformant
After dissolving in 0t / 0.1E, size marker DNA (lambda
DNA: 48 Kbp, Lambda DNA digested with HindIII: 22.3 Kb
p, 9.5 Kbp) and 0.4% agarose gel electrophoresis, 20 of the ampicillin resistant colonies
All plasmids range in size from 22.3 Kbp to 48 Kbp
Presence of DNA was observed.

【図面の簡単な説明】[Brief description of drawings]

第1図は新規コスミドベクターpDcos Apr/oriを示し、 第2図は第1図の新規コスミドベクターを用いるゲノム
DNAの遺伝子バンクの製造法を示し、 第3図は新規コスミドベクターpDcos Tcrを示し、 第4図は新規コスミドベクターpDcos Tcr/oriを示し、 第5図は新規コスミドベクターpDcos Apr/ori/gpt/TKを
示し、 第6図はpDcos Tcrの作成方法を示し、 第7図はpDcos Tcr/oriの作成方法を示し、 第8図はpDcos Apr/oriの作成方法を示し、 第9図はpDcos Apr/ori/gpt/TKの作成方法を示す。
Figure 1 shows the new cosmid vector pDcos Ap r / ori, and Figure 2 shows the genome using the new cosmid vector of Figure 1.
Shows the preparation of DNA of the gene bank, Figure 3 shows a novel cosmid vector pDcos Tc r, Figure 4 shows a novel cosmid vector pDcos Tc r / ori, Fig. 5 new cosmid vector pDcos Ap r / ori / gpt / TK, Fig. 6 shows how to make pDcos Tc r , Fig. 7 shows how to make pDcos Tc r / ori, Fig. 8 shows how to make pDcos Ap r / ori, FIG. 9 shows a method for creating pDcos Ap r / ori / gpt / TK.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 岡田 善雄 大阪府箕面市半町2−22―28 (56)参考文献 Gene,26,[1983]P.137−146 ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Yoshio Okada 2-22-28 Hanmachi, Minoh City, Osaka Prefecture (56) References Gene, 26, [1983] p. 137-146

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】同一の方向性を持った下記の cos :ラムダファージのcos ori :複製開始点 Apr:アンピシリン耐性を発現する領域 neor:ネオマイシン耐性を発現する領域 で示されるコスミドベクターpDcosApr/oriおよび下記の cos:ラムダファージのcos ori:複製開始点 Tcr:テトラサイクリン耐性を発現する領域 で示されるコスミドベクターpDcos Tcrおよび下記の cos:ラムダファージのcos ori:複製開始点 Tcr:テトラサイクリン耐性を発現する領域 SV−dhfr:SV−40 ジヒドロ葉酸リダクターゼ活性を発
現する領域 で示されるコスミドベクターpDcos Tcr/oriまたは下記
cos:ラムダファージのcos ori:複製開始点 Apr:アンピシリン耐性を発現する領域 SV−dhfr:SV−40 ジヒドロ葉酸リダクターゼ活性を発
現する領域 TK:チミジンキナーゼ活性を発現する領域 gpt:キサンチングアニンホスホリボシルトランス
フェラーゼ活性を発現する領域 で示されるコスミドベクターpDcos Apr/ori/gpt/TKであ
るcosを2個有し、2種類の制限酵素で切ることによっ
て、それぞれcosを1個づつ持った長さがほぼ等しい右
腕と左腕とが等モルできるようにしたことを特徴とする
新規コスミドベクター。
1. The following having the same directionality: cos: Lambda phage cos ori: Origin of replication Ap r : Ampicillin resistance expressing region neo r : Neomycin resistance expressing cosmid vector pDcosAp r / ori and the following cos: cos ori of lambda phage: origin of replication Tc r : cosmid vector pDcos Tc r shown in the region expressing tetracycline resistance and cos: cos ori of lambda phage: origin of replication Tc r : region expressing tetracycline resistance SV-dhfr: SV-40 cosmid vector pDcos Tc r / ori shown in the region expressing dihydrofolate reductase activity or cos: cos ori of lambda phage: origin of replication Ap r : region expressing ampicillin resistance SV-dhfr: SV-40 region expressing dihydrofolate reductase activity TK: region expressing thymidine kinase activity gpt: xanthine guanine phosphoribosyl The cosmid vector pDcos Ap r / ori / gpt / TK, which has a cosmid vector that expresses transferase activity, has two cos, and each cosmid has a length of 1 by cutting with 2 types of restriction enzymes. A novel cosmid vector characterized in that the right arm and the left arm can be equimolar to each other.
【請求項2】コスミドベクター由来の遺伝子画分の挿入
を判定するための薬剤耐性、もしくは特定の生理機能を
発現せしめる遺伝子配列を含有する特許請求の範囲第1
項記載の新規コスミドベクター。
2. The method according to claim 1, which contains a gene sequence for expressing drug resistance or a specific physiological function for determining the insertion of a gene fraction derived from a cosmid vector.
A novel cosmid vector according to the item.
【請求項3】薬剤耐性としてアンピシリン耐性、テトラ
サイクリン耐性、ネオマイシン耐性もしくはクロラムフ
エニコール耐性を発現せしめる遺伝子配列を有する特許
請求の範囲第2項記載の新規コスミドベクター。
3. The novel cosmid vector according to claim 2, which has a gene sequence capable of expressing ampicillin resistance, tetracycline resistance, neomycin resistance or chloramphenicol resistance as drug resistance.
【請求項4】特定の生理機能として、アミノグリコシド
3′−ホスホトランスフエラーゼ(neo)活性、チミジ
ンキナーゼ(TK)活性、アデニンホスホリボシルトラン
スフエラーゼ(APRT)活性、ヒポキサンチングアニンホ
スホリボシルトランスフエラーゼ(HGPRT)活性、キサ
ンチングアニンホスホリボシルトランスフエラーゼ(XG
PRT又はgpt)活性、もしくはジヒドロ葉酸リダクターゼ
(dhfr)活性を発現せしめる遺伝子配列を有する特許請
求の範囲第2項記載の新規コスミドベクター。
4. As specific physiological functions, aminoglycoside 3'-phosphotransferase (neo) activity, thymidine kinase (TK) activity, adenine phosphoribosyl transferase (APRT) activity, hypoxanthine anine phosphoribosyl transferase. (HGPRT) activity, xanthine guanine phosphoribosyl transferase (XG
The novel cosmid vector according to claim 2, which has a gene sequence capable of expressing PRT or gpt) activity or dihydrofolate reductase (dhfr) activity.
【請求項5】Col EI由来の複製機能を有する遺伝子画分
を含有する特許請求の範囲第2項記載の新規コスミドベ
クター。
5. The novel cosmid vector according to claim 2, which contains a gene fraction having a replication function derived from Col EI.
JP59112206A 1984-06-02 1984-06-02 New cosmid vector Expired - Lifetime JPH0824580B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59112206A JPH0824580B2 (en) 1984-06-02 1984-06-02 New cosmid vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59112206A JPH0824580B2 (en) 1984-06-02 1984-06-02 New cosmid vector

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP9511694A Division JP2599892B2 (en) 1994-05-09 1994-05-09 A method for producing a gene bank using a novel cosmid vector

Publications (2)

Publication Number Publication Date
JPS60256382A JPS60256382A (en) 1985-12-18
JPH0824580B2 true JPH0824580B2 (en) 1996-03-13

Family

ID=14580906

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59112206A Expired - Lifetime JPH0824580B2 (en) 1984-06-02 1984-06-02 New cosmid vector

Country Status (1)

Country Link
JP (1) JPH0824580B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61132187A (en) * 1984-11-30 1986-06-19 Banyu Pharmaceut Co Ltd Novel cosmid vector and production of gene bank using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Gene,26,[1983P.137−146

Also Published As

Publication number Publication date
JPS60256382A (en) 1985-12-18

Similar Documents

Publication Publication Date Title
Nellen et al. DNA-mediated transformation in Dictyostelium discoideum: regulated expression of an actin gene fusion
JP3038479B2 (en) Transformation of plant protoplasts
Brosius et al. Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli
Gryczan et al. Characterization of Staphylococcus aureus plasmids introduced by transformation into Bacillus subtilis
AU648951B2 (en) Agrobacterium mediated transformation of germinating plant seeds
JPS63159397A (en) Recombinant b-type hepatitis virus antigen
GB2052516A (en) Plasmid vectors production and use thereof
JPH0838179A (en) Improved e.coli host cell
JPS61502166A (en) Improved methods and vectors for transformation of plant cells
KR920009543B1 (en) β-urogastron gene, corresponding recombinant plasmid, corresponding transformant and preparation method thereof, and preparation method of β-urogastron
CN111575319A (en) Efficient CRISPR RNP and donor DNA co-location mediated gene insertion or replacement method and application thereof
JPH0824580B2 (en) New cosmid vector
Enger-Valk et al. Construction of new cloning vehicles with genes of the tryptophan operon of Escherichia coli as genetic markers
US4393137A (en) Cloning plasmid for streptomyces
Nagahari Deletion plasmids from transformants of Pseudomonas aeruginosa trp cells with the RSF1010-trp hybrid plasmid and high levels of enzyme activity from the gene on the plasmid
EP0183571A2 (en) Cosmid vectors
Manch et al. Ordering tryptophan synthase genes of Pseudomonas aeruginosa by cloning in Escherichia coli
JP2599892B2 (en) A method for producing a gene bank using a novel cosmid vector
JPS63185386A (en) Production of peptides
Otsuka et al. Cloning of the marmoset herpesvirus thymidine kinase gene and analyses of the boundaries of the coding region
RU2077586C1 (en) RECOMBINANT PLASMID DNA PTHY 315 ENCODING HYBRID PROTEIN TUMOR NECROSIS α-FACTOR - THYMOSIN-a1
Martinez et al. Complementation of Bacillus subtilis polA mutants by DNA polymerase I from Streptococcus pneumoniae
WO2025039972A1 (en) Tls-based gene editing systems
JP3302053B2 (en) Gene involved in production of oxetanosine-A and recombinant DNA containing the same
JP3495379B2 (en) Method for directly transferring a vector plasmid by conjugation and vector plasmid used for the method